The present subject matter relates to orthopedic prostheses and, more particularly, to prostheses and systems used in knee arthroplasties including revision knee arthroplasties.
Orthopedic procedures and prostheses are commonly utilized to repair and/or replace damaged bone and tissue in the human body. For example, a knee arthroplasty can be used to restore natural knee function by repairing damaged or diseased articular surfaces of the femur and/or tibia. An incision is made into the knee joint to expose the bones comprising the joint. Cut guides are used to guide the removal of the articular surfaces that are to be replaced. Prostheses are used to replicate the articular surfaces. Knee prostheses can include a femoral prosthesis implanted on the distal end of the femur, which articulates with a tibial bearing component and a tibial component implanted on the proximal end of a tibia to replicate the function of a healthy natural knee. Various types of arthroplasties are known including a total knee arthroplasty, where all of the articulating compartments of the joint are repaired with prosthetic components.
This disclosure pertains generally to femoral prostheses and systems for a knee arthroplasty including a revision knee arthroplasty. The present inventors have recognized, among other things, that it is desirable to offer versatile sizing options with regards to a combination of femoral posterior condylar offset and femoral medial-lateral condylar extent. More particularly, the present inventors have recognized a femoral prosthesis system that can have a plurality of sizing options using two families of femoral prostheses. The second family of femoral prostheses has a predetermined increase in the femoral posterior condylar offset relative to the first family of femoral prosthesis. In one example, the second family of femoral prostheses can have the predetermined increase in the femoral posterior condylar offset while maintaining substantially the same femoral medial-lateral condylar extent relative to the first family of femoral prostheses. Thus, for example, if sizing criteria dictate, a femoral prosthesis of a first size from the second family can be selected having a relatively larger femoral posterior condylar offset but a same femoral medial-lateral condylar extent to a correspondingly sized femoral prosthesis from the first family. Similarly, the systems allow for downsizing should sizing criteria dictate. For example, a femoral prosthesis of a first size from the first family can be selected having a femoral medial-lateral condylar extent that is larger than desired but having a femoral posterior condylar offset that is sized as desired. In such situation, the disclosed examples allow a correspondingly sized femoral prosthesis from the second family to be selected that has substantially a same femoral posterior condylar offset but a femoral medial-lateral condylar extent that differs from that of the femoral prosthesis of the first size from the first family by a predetermined amount. Such sizing versatility allows a patient appropriate femoral prosthesis from the first family or the second family to be selected more easily (e.g., selection is made using a consistent logical upsizing or downsizing scheme).
Regarding the first family of femoral prostheses, according to one example, the first family of femoral prostheses have a first range of posterior condylar offsets and a corresponding range of femoral medial-lateral condylar extents. The range for the femoral medial-lateral condylar extent of the first family can be between about 59 mm (for a size 1 femoral prosthesis) and about 80 mm (for a size 13 femoral prosthesis), for example. Similarly, the range of the posterior condylar offset can be between about 33 mm (for the size 1 femoral prosthesis) to about 52 mm (for the size 13 femoral prosthesis), for example. According to some examples, the femoral medial-lateral condylar extent can be substantially linearly incremented in a size increase from the size 1 to the size 13 femoral prosthesis such that for each increase in femoral size (e.g., going from a size 1 to size 3 or from a size 7 to a size 9) there is a corresponding known increase in the femoral medial-lateral condylar extent. The posterior condylar offset can be similarly substantially linearly incremented such that there is a known increase when moving up or down in prostheses size.
The present inventors have additionally recognized the prosthesis system can have the second family of femoral prostheses be compatible with the same tibial bearing component as a correspondingly sized femoral prosthesis from the first family of femoral prostheses. According to some examples, the second family of femoral prostheses can have a second range of posterior condylar offsets and corresponding femoral medial-lateral condylar extents. The range for the femoral medial-lateral condylar extent of the first family can be between about 59 mm (for a size 1+ femoral prosthesis) and about 77 mm (for a size 11+ femoral prosthesis), for example. Similarly, the range of the posterior condylar offset can be between about 37 mm (for the size 1+ femoral prosthesis) to about 52 mm (for the size 11+ femoral prosthesis), for example. According to some examples, the femoral medial-lateral condylar extent can be substantially linearly incremented in a size increase from the size 1+ to the size 11+ femoral prosthesis such that for each increase in femoral size there is a corresponding increase in the femoral medial-lateral condylar extent. The posterior condylar offset can be similarly substantially linearly incremented such that there is a known increase when moving up or down in prostheses size.
As discussed above, the size increase for the first family of femoral prostheses and the size increase for the second family of femoral prostheses can be related so as to be substantially the same (See
To further illustrate the apparatuses and systems disclosed herein, the following non-limiting examples are provided:
Example 1 is a system for knee arthroplasty that can optionally include: a first family having a first plurality of femoral prostheses with different stock sizes from one another, each of the first plurality of femoral prostheses having: a first stem housing extending along a first axis; and a first medial condyle and a first lateral condyle coupled to the first stem housing; wherein the first medial condyle and the first lateral condyle have a first posterior condylar offset as measured from the first axis to a first posterior-most point of the first medial condyle and the first lateral condyle; and wherein the first medial condyle and the first lateral condyle have a first femoral medial-lateral condylar extent from a medial most edge of the first medial condyle to a lateral most edge of the first lateral condyle; a second family having a second plurality of femoral prostheses with different stock sizes from one another, each of the second plurality of femoral prostheses having: a second stem housing extending along a second axis; and a second medial condyle and a second lateral condyle coupled to the second stem housing; wherein the second medial condyle and the second lateral condyle have a second posterior condylar offset from the second axis to a second posterior-most point of the second medial condyle and the second lateral condyle; and wherein the second medial condyle and the second lateral condyle have a second femoral medial-lateral condylar extent from a medial most edge of the second medial condyle to a lateral most edge of the second lateral condyle; wherein the first femoral medial-lateral condylar extent of at least one of the first plurality of femoral prostheses and the second femoral medial-lateral condylar extent of at least one of the second plurality of femoral prostheses are substantially the same.
In Example 2, the subject matter of Example 1 optionally can include the at least one of the first plurality of femoral prostheses and the at least one of the second plurality of femoral prostheses are configured to articulate with a same tibial bearing component.
In Example 3, the subject matter of any one or more of Examples 1-2 optionally can include the first posterior condylar offset of the at least one of the first plurality of femoral prostheses and the second posterior condylar offset of the at least one of the second plurality of femoral prostheses differ by a predetermined amount.
In Example 4, the subject matter of any one or more of Examples 1-3 optionally can include the predetermined amount comprises substantially 3 mm, and wherein the second medial condyle and a second lateral condyle are thickened along a posterior portion comprising at least a region between a posterior bone-contacting surface and a posterior portion of the J-curve when viewed in a sagittal plane relative to a corresponding thickness of the first medial condyle and the first lateral condyle.
In Example 5, the subject matter of any one or more of Examples 1-4 optionally can include the first posterior condylar offset of at least four of the first plurality of the femoral prostheses is substantially the same as the second posterior condylar offset of at least four of the second plurality of femoral prostheses.
In Example 6, the subject matter of any one or more of Examples 1-5 optionally include the first posterior condylar offset of at least six of the first plurality of the femoral prostheses is substantially the same as the second posterior condylar offset of at least six of the second plurality of femoral prostheses.
In Example 7, the subject matter of any one or more of Examples 1-6 optionally can include the first femoral medial-lateral condylar extent of at least four of the first plurality of the femoral prostheses is substantially the same as the second femoral medial-lateral condylar extent of at least four of the second plurality of femoral prostheses.
In Example 8, the subject matter of any one or more of Examples 1-7 optionally can include the first femoral medial-lateral condylar extent of at least six of the first plurality of the femoral prostheses is substantially the same as the second femoral medial-lateral condylar extent of at least six of the second plurality of femoral prostheses.
In Example 9, the subject matter of any one or more of Examples 1-8 optionally can include each of the different stock sizes of the first plurality of femoral prostheses differ with respect to the first femoral medial-lateral condylar extent by a first amount between a smaller size and a next larger size and each of the different stock sizes of the second plurality of femoral prostheses differ with respect to the second femoral medial-lateral condylar extent by a second amount between a corresponding smaller size and a corresponding next larger size, and wherein the first amount is substantially the same as the second amount.
In Example 10, the subject matter of any one or more of Examples 1-9 optionally can include each of the different stock sizes of the first plurality of femoral prostheses differ with respect to the first posterior condylar offset by a third amount between a smaller size and a next larger size and each of the different stock sizes of the second plurality of femoral prostheses differ with respect to the second posterior condylar offset by a fourth amount between a corresponding smaller size and a corresponding next larger size, and wherein the third amount is substantially the same as the fourth amount.
Example 11 is a system for knee arthroplasty can optionally include: a first family having a first plurality of femoral prostheses with different stock sizes from one another, each of the first plurality of femoral prostheses having: a first stem housing extending along a first axis; and a first medial condyle and a first lateral condyle coupled to the first stem housing; wherein the first medial condyle and the first lateral condyle have a first posterior condylar offset as measured from the first axis to a first posterior-most point of the first medial condyle and the first lateral condyle; and wherein the first medial condyle and the first lateral condyle have a first femoral medial-lateral condylar extent as measured from a medial most edge of the first medial condyle to a lateral most edge of the first lateral condyle; a second family having a second plurality of femoral prostheses with different stock sizes from one another, each of the second plurality of femoral prostheses having: a second stem housing extending along a second axis; and a second medial condyle and a second lateral condyle coupled to the second stem housing, wherein the second medial condyle and the second lateral condyle have a second posterior condylar offset as measured from the second axis to a second posterior-most point of the second medial condyle and the second lateral condyle; and wherein the second medial condyle and the second lateral condyle have a second femoral medial-lateral condylar extent as measured from a medial most edge of the second medial condyle to a lateral most edge of the second lateral condyle; wherein the first posterior condylar offset of at least one of the first plurality of femoral prostheses and the second posterior condylar offset of at least one of the second plurality of femoral prostheses are substantially the same; and wherein the first femoral medial-lateral condylar extent of the at least one of the first plurality of femoral prostheses and the second femoral medial-lateral condylar extent of the at least one of the second plurality of femoral prostheses differ by a first predetermined amount.
In Example 12, the subject matter of Example 11 optionally can include at least one of the first medial condyle and the first lateral condyle have a first thickness at a posterior portion between a first posterior bone-contacting surface and the first posterior-most point and at least one of the second medial condyle and the second lateral condyle have a second thickness at a corresponding posterior portion between a second posterior bone-contacting surface and the second posterior-most point, and wherein the first thickness differs from the second thickness by a second predetermined amount.
In Example 13, the subject matter of Example 12 optionally can include a third thickness of the at least one of the first medial condyle and the first lateral condyle as measured between a first posterior chamfer and an articular surface differs by a third predetermined amount from a fourth thickness of at least one of the second medial condyle and the second lateral condyle as measured between a corresponding second posterior chamfer and a corresponding articular surface.
In Example 14, the subject matter of Example 13 optionally can include an anterior bone-contacting surface of the at least one of the second plurality of femoral prostheses is disposed relatively nearer the second axis by a fourth predetermined amount than a corresponding anterior bone-contacting surface of the at least one of the first plurality of femoral prostheses.
In Example 15, the subject matter of Example 14 optionally can include one or both of the first predetermined amount and the second predetermined amount comprises substantially 3 mm, the third predetermined amount comprises substantially 1 mm and the fourth predetermined amount comprises substantially 1 mm.
In Example 16, the subject matter of any one or more of Examples 11-15 optionally can include the at least one of the first plurality of femoral prostheses and the at least one of the second plurality of femoral prostheses are configured to articulate with a same tibial bearing component.
In Example 17, the subject matter of any one or more of Examples 11-16 optionally can include the first posterior condylar offset of at least four of the first plurality of the femoral prostheses is substantially the same as the second posterior condylar offset of at least four of the second plurality of femoral prostheses.
In Example 18, the subject matter of any one or more of Examples 11-17 optionally can include the first posterior condylar offset of at least six of the first plurality of the femoral prostheses is substantially the same as the second posterior condylar offset of at least six of the second plurality of femoral prostheses.
In Example 19, the subject matter of any one or more of Examples 11-18 optionally can include the first femoral medial-lateral condylar extent of at least four of the first plurality of the femoral prostheses is substantially the same as the second femoral medial-lateral condylar extent of at least four of the second plurality of femoral prostheses.
In Example 20, the subject matter of any one or more of Examples 11-19 optionally can include the first femoral medial-lateral condylar extent of at least six of the first plurality of the femoral prostheses is substantially the same as the second femoral medial-lateral condylar extent of at least six of the second plurality of femoral prostheses.
In Example 21, the subject matter of any one or more of Examples 11-20 optionally can include each of the different stock sizes of the first plurality of femoral prostheses differ with respect to the first femoral medial-lateral condylar extent by a first amount between a smaller size and a next larger size and each of the different stock sizes of the second plurality of femoral prostheses differ with respect to the second femoral medial-lateral condylar extent by a second amount between a corresponding smaller size and a corresponding next larger size, and wherein the first amount is substantially the same as the second amount.
In Example 22, the subject matter of any one or more of Examples 11-21 optionally can include each of the different stock sizes of the first plurality of femoral prostheses differ with respect to the first posterior condylar offset by a third amount between a smaller size and a next larger size and each of the different stock sizes of the second plurality of femoral prostheses differ with respect to the second posterior condylar offset by a fourth amount between a corresponding smaller size and a corresponding next larger size, and wherein the third amount is substantially the same as the fourth amount.
In Example 23, the systems of any one or any combination of Examples 1-22 can optionally be configured such that all elements or options recited are available to use or select from.
These and other examples and features of the present devices and systems will be set forth in part in the following Detailed Description. This overview is intended to provide a summary of subject matter of the present patent application. It is not intended to provide an exclusive or exhaustive removal of the invention. The detailed description is included to provide further information about the present patent application.
In the drawings, which are not necessarily drawn to scale, like numerals can describe similar components in different views. Like numerals having different letter suffixes can represent different instances of similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various examples discussed in the present document.
The present application relates femoral prostheses and systems. The systems, for example, can include a first family having a first plurality of femoral prostheses with different stock sizes from one another. The system can additional include a second family having a second plurality of femoral prostheses with different stock sizes from one another. Each of the first plurality of femoral prostheses can have a first stem housing extending along a first axis and a first medial condyle and a first lateral condyle coupled to the first stem housing. The first medial condyle and the first lateral condyle can have a first posterior condylar offset as measured from the first axis to a first posterior-most point of the first medial condyle and the first lateral condyle. The first medial condyle and the first lateral condyle can have a first femoral medial-lateral condylar extent as measured from a medial most edge of the first medial condyle to a lateral most edge of the first lateral condyle. Similarly, the second stem housing can extending along a second axis and a second medial condyle and a second lateral condyle can be coupled to the second stem housing. The second medial condyle and the second lateral condyle can have a second posterior condylar offset as measured from the second axis to a second posterior-most point of the second medial condyle and the second lateral condyle. The second medial condyle and the second lateral condyle can have a second femoral medial-lateral condylar extent as measured from a medial most edge of the second medial condyle to a lateral most edge of the second lateral condyle. The first femoral medial-lateral condylar extent of at least one of the first plurality of femoral prostheses and the second femoral medial-lateral condylar extent of at least one of the second plurality of femoral prostheses can be substantially the same according to some examples.
The present application relates to prostheses and systems that can be used in a knee arthroplasty and/or as part of a later knee revision surgery. As described herein, the term system or assembly can include both tibial prosthesis and a femoral prosthesis. This application focuses on aspects of the femoral prosthesis, which can include the stem housing, the medial condyle and the lateral condyle. As discussed previously, the femoral prostheses can be part of the system used to simplify sizing and offer various femoral options that can be compatible with the same tibial bearing component. Additional features and benefits of the various examples provided herein will be discussed and/or will be apparent to one of ordinary skill in the art.
As used herein, the terms “proximal” and “distal” should be given their generally understood anatomical interpretation. The term “proximal” refers to a direction generally toward the torso of a patient, and “distal” refers to the opposite direction of proximal, i.e., away from the torso of a patient. It should be understood that the use of the terms “proximal” and “distal” should be interpreted as though the patient were standing with the knee joint in extension despite the apparatuses described herein generally being used with the knee joint in flexion. The intent is to differentiate the terms “proximal” and “distal” from the terms “anterior” and “posterior”. As used herein, the terms “anterior” and “posterior” should be given their generally understood anatomical interpretation. Thus, “posterior” refers to a rear of the patient, e.g., a back of the knee. Similarly, “anterior” refers to a front of the patient, e.g., a front of the knee. Thus, “posterior” refers to the opposite direction of“anterior”. Similarly, the term “lateral” refers to the opposite direction of “medial”.
According to the examples provided herein, the prosthesis assembly 10 and system 12 can utilize posterior stabilized (PS) prostheses. Thus, the tibial prosthesis 15 can include a spine 16 and the femoral prosthesis 14 can include a cam 18 (
Turning to the components illustrated in
As shown in
The tibial bearing component 26 can be secured to the tibial baseplate 24 as shown in
The cam 18 can be positioned at a posterior end of the intercondylar space 23 and can extend between the medial and lateral condyles 20 and 22. As shown in
The posterior bone-interfacing surface 40, the posterior bone-interfacing chamfer surface 42, the distal bone-interfacing surface 44, the anterior bone-interfacing chamfer surface 46 and the anterior bone-interfacing surface 48 are configured to abut resected portions of the femur (not shown) upon implantation of the femoral prosthesis 14. The stem housing 50 can be positioned generally between the medial and lateral condyles 20 and 22 and can be coupled thereto. The stem housing 50 can be positioned anterior of the intercondylar space 23. The stem housing 50 can extend generally proximally and can be symmetrical about a first axis A as shown in
However, as shown in
Due to the difference between the thickness 104 and the thickness 204, the femoral prosthesis 114 can have a posterior condylar offset 108 that differs from a posterior condylar offset 208 of the femoral prosthesis 214. According to some examples, the posterior condylar offset 108 can differ from the posterior condylar offset 208 by a predetermined amount (e.g., 1, 2, 3, 4 or 5 mm). Indeed, in the illustrated embodiment of
The medial-lateral condylar extent 306 can be from a medial most edge 310 of a medial condyle 320 to a lateral most edge 312 of a lateral condyle 322. The posterior condylar offset 308 can extend from an axis A of a stem housing 314 to a posterior-most point P of at least one of the medial condyle 320 and the lateral condyle 322.
According to the example of
Similarly, the femoral medial-lateral condylar extent of at least four of the first family of femoral prostheses 302 (the first family of femoral prostheses 302 being of different distinct sizes from one another) can substantially the same as the femoral medial-lateral condylar extent of at least four of the second family of femoral prostheses 304 (the second family of femoral prosthesis 304 being of different distinct sizes from one another). According to some examples, the femoral medial-lateral condylar extent of at least six of the first family of femoral prostheses 302 can be substantially the same as the femoral medial-lateral condylar extent of at least six of the second family of femoral prostheses 304 (e.g., sizes 1 and 1+ can have substantially the same femoral medial-lateral condylar extent, sizes 3 and 3+ can have substantially femoral medial-lateral condylar extent, sizes 5 and 5+ can have substantially the same femoral medial-lateral condylar extent, sizes 7 and 7+ can have substantially the same femoral medial-lateral condylar extent, sizes 9 and 9+ can have substantially the same femoral medial-lateral condylar extent and sizes 11 and 11+ can share substantially the same femoral medial-lateral condylar extent).
As shown in
The family of tibial baseplates 350 can have at least nine different stock sizes A to J. As shown in
According to further examples, eleven of the at least thirteen different stock sizes of the first and second families of femoral prostheses 302, 304 can be compatible for operable use with nine of the at least eleven different stock sizes of the family of tibial bearing components 352. According to further examples, twelve of the at least thirteen different stock sizes of the first and second families of femoral prostheses 302, 304 can be compatible for operable use with at least two of the at least eleven different stock sizes of the tibial bearing baseplates 350.
This overlapping sizing and the provision of many different compatible sizes can have benefits including providing for increased stability of the medial condyle of the femoral prosthesis. Additionally, the overlapping sizing allows for the flexion fill and downsizing in the femoral medial-lateral condylar extent as discussed previously with respect to
As shown in
According to the example of
In some examples, an anterior bone-contacting surface 426 of the second prosthesis 404 (one of the second plurality of femoral prostheses 304 previously discussed) can be disposed relatively nearer to a stem housing axis A by another predetermined amount Z than a corresponding anterior bone-contacting surface 428 of the first prosthesis 402 (one of the first plurality of femoral prostheses 302).
As previously discussed, the downsizing in the femoral medial-lateral condylar extent can be by a predetermined amount (e.g., a few mm). Similarly, the predetermined amount X can be substantially 3 mm (or another desired amount), the predetermined amount Y can comprise substantially 1 mm (or another desired amount) and the predetermined amount Z comprises substantially 1 mm (or another desired amount).
At least one of the first medial condyle and the first lateral condyle 406 and at least one of the second medial condyle and the second lateral condyle 408 can have a similar sagittal J-curve 430 along a posterior and distal portion thereof 432 from the first and second posterior-most points P1 and P2, respectively, to a point distal of the stem housing 434, respectively.
The above detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention can be practiced. These embodiments are also referred to herein as “examples.” Such examples can include elements in addition to those shown or described. However, the present inventors also contemplate examples in which only those elements shown or described are provided. Moreover, the present inventors also contemplate examples using any combination or permutation of those elements shown or described (or one or more aspects thereof), either with respect to a particular example (or one or more aspects thereof), or with respect to other examples (or one or more aspects thereof) shown or described herein.
In this document, the terms “a” or “an” are used, as is common in patent documents, to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.” In this document, the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B,” “B but not A,” and “A and B,” unless otherwise indicated. In this document, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein.” Also, in the following claims, the terms “including” and “comprising” are open-ended, that is, a system, device, article, composition, formulation, or process that includes elements in addition to those listed after such a term in a claim are still deemed to fall within the scope of that claim. Moreover, in the following claims, the terms “first,” “second,” and “third,” etc. are used merely as labels, and are not intended to impose numerical requirements on their objects.
The above description is intended to be illustrative, and not restrictive. For example, the above-described examples (or one or more aspects thereof) can be used in combination with each other. Other examples can be used, such as by one of ordinary skill in the art upon reviewing the above description. The Abstract is provided to comply with 37 C.F.R. § 1.72(b), to allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. Also, in the above detailed description, various features can be grouped together to streamline the disclosure. This should not be interpreted as intending that an unclaimed disclosed feature is essential to any claim. Rather, inventive subject matter can lie in less than all features of a particular disclosed example. Thus, the following claims are hereby incorporated into the detailed description as examples or embodiments, with each claim standing on its own as a separate example, and it is contemplated that such examples can be combined with each other in various combinations or permutations. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application is a continuation of U.S. patent application Ser. No. 15/971,743, filed on May 4, 2018, which claims the benefit of U.S. Provisional Patent Application Ser. No. 62/505,322, filed on May 12, 2017, the benefit of priority of each of which is claimed hereby, and each of which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3774244 | Walker | Nov 1973 | A |
4016606 | Murray et al. | Apr 1977 | A |
4257129 | Volz | Mar 1981 | A |
4340978 | Buechel et al. | Jul 1982 | A |
4501266 | McDaniel | Feb 1985 | A |
4568348 | Johnson et al. | Feb 1986 | A |
4673408 | Grobbelaar | Jun 1987 | A |
4711639 | Grundei | Dec 1987 | A |
4714474 | Brooks, Jr. et al. | Dec 1987 | A |
4759767 | Lacey | Jul 1988 | A |
4769040 | Wevers | Sep 1988 | A |
4770661 | Oh | Sep 1988 | A |
4795468 | Hodorek et al. | Jan 1989 | A |
4822365 | Walker et al. | Apr 1989 | A |
4936853 | Fabian et al. | Jun 1990 | A |
4944756 | Kenna | Jul 1990 | A |
4944757 | Martinez et al. | Jul 1990 | A |
4950298 | Gustilo et al. | Aug 1990 | A |
4959071 | Brown et al. | Sep 1990 | A |
4963152 | Hofmann et al. | Oct 1990 | A |
5007933 | Sidebotham et al. | Apr 1991 | A |
5047057 | Lawes | Sep 1991 | A |
5047058 | Roberts | Sep 1991 | A |
5059216 | Winters | Oct 1991 | A |
5061271 | Van Zile | Oct 1991 | A |
5071438 | Jones et al. | Dec 1991 | A |
5108442 | Smith | Apr 1992 | A |
5116375 | Hofmann | May 1992 | A |
5133758 | Hollister | Jul 1992 | A |
5137536 | Koshino | Aug 1992 | A |
5147405 | Van Zile | Sep 1992 | A |
5171283 | Pappas et al. | Dec 1992 | A |
5192328 | Winters | Mar 1993 | A |
5194066 | Van Zile | Mar 1993 | A |
5197488 | Kovacevic | Mar 1993 | A |
5219362 | Tuke et al. | Jun 1993 | A |
5226915 | Bertin | Jul 1993 | A |
5236461 | Forte | Aug 1993 | A |
5246459 | Elias | Sep 1993 | A |
5271737 | Baldwin et al. | Dec 1993 | A |
5275603 | Ferrante et al. | Jan 1994 | A |
5282861 | Kaplan | Feb 1994 | A |
5282868 | Bahler | Feb 1994 | A |
5282870 | Moser et al. | Feb 1994 | A |
5290313 | Heldreth | Mar 1994 | A |
5310480 | Vidueira | May 1994 | A |
5326361 | Hollister | Jul 1994 | A |
5344460 | Turanyi et al. | Sep 1994 | A |
5344461 | Phlipot | Sep 1994 | A |
5360016 | Kovacevic | Nov 1994 | A |
5364402 | Mumme et al. | Nov 1994 | A |
5370699 | Hood et al. | Dec 1994 | A |
5387239 | Bianco et al. | Feb 1995 | A |
5387240 | Pottenger et al. | Feb 1995 | A |
5395401 | Bahler | Mar 1995 | A |
5405396 | Heldreth et al. | Apr 1995 | A |
5413604 | Hodge | May 1995 | A |
5413605 | Ashby et al. | May 1995 | A |
5425775 | Kovacevic et al. | Jun 1995 | A |
5445642 | McNulty et al. | Aug 1995 | A |
5458637 | Hayes | Oct 1995 | A |
5470354 | Hershberger et al. | Nov 1995 | A |
5489311 | Cipolletti | Feb 1996 | A |
5507820 | Pappas | Apr 1996 | A |
5549688 | Ries et al. | Aug 1996 | A |
5556433 | Gabriel et al. | Sep 1996 | A |
5571194 | Gabriel | Nov 1996 | A |
5609639 | Walker | Mar 1997 | A |
5609641 | Johnson et al. | Mar 1997 | A |
5609643 | Colleran et al. | Mar 1997 | A |
5609645 | Vinciuerra | Mar 1997 | A |
5613970 | Houston et al. | Mar 1997 | A |
5656785 | Trainor et al. | Aug 1997 | A |
5658341 | Delfosse | Aug 1997 | A |
5658342 | Draganich et al. | Aug 1997 | A |
5658344 | Hurlburt | Aug 1997 | A |
5683470 | Johnson et al. | Nov 1997 | A |
5702463 | Pothier et al. | Dec 1997 | A |
5702464 | Lackey et al. | Dec 1997 | A |
5733292 | Gustilo et al. | Mar 1998 | A |
5755801 | Walker et al. | May 1998 | A |
5755802 | Gerber | May 1998 | A |
5776200 | Johnson et al. | Jul 1998 | A |
5782925 | Collazo et al. | Jul 1998 | A |
5824100 | Kester et al. | Oct 1998 | A |
5824102 | Buscayret | Oct 1998 | A |
5824103 | Williams et al. | Oct 1998 | A |
5871539 | Pappas | Feb 1999 | A |
5871541 | Gerber | Feb 1999 | A |
5871543 | Hofmann | Feb 1999 | A |
5871545 | Goodfellow et al. | Feb 1999 | A |
5879394 | Ashby et al. | Mar 1999 | A |
5906643 | Walker | May 1999 | A |
5911723 | Ashby et al. | Jun 1999 | A |
5928286 | Ashby et al. | Jul 1999 | A |
5964808 | Blaha et al. | Oct 1999 | A |
5968099 | Badorf et al. | Oct 1999 | A |
5976147 | LaSalle et al. | Nov 1999 | A |
6004351 | Tomita et al. | Dec 1999 | A |
6004352 | Buni | Dec 1999 | A |
6010534 | O'neil et al. | Jan 2000 | A |
6013103 | Kaufman et al. | Jan 2000 | A |
6039764 | Pottenger et al. | Mar 2000 | A |
6068658 | Insall et al. | May 2000 | A |
6074425 | Pappas | Jun 2000 | A |
6080195 | Colleran et al. | Jun 2000 | A |
6090144 | Letot et al. | Jul 2000 | A |
6102954 | Albrektsson et al. | Aug 2000 | A |
6102955 | Mendes et al. | Aug 2000 | A |
6123729 | Insall et al. | Sep 2000 | A |
6126692 | Robie et al. | Oct 2000 | A |
6143034 | Burrows | Nov 2000 | A |
6197064 | Haines et al. | Mar 2001 | B1 |
6203576 | Afriat et al. | Mar 2001 | B1 |
6206927 | Fell et al. | Mar 2001 | B1 |
6210443 | Marceaux et al. | Apr 2001 | B1 |
6217618 | Hileman | Apr 2001 | B1 |
RE37277 | Baldwin et al. | Jul 2001 | E |
6258127 | Schmotzer | Jul 2001 | B1 |
6306172 | O'Neil et al. | Oct 2001 | B1 |
6325828 | Dennis et al. | Dec 2001 | B1 |
6379388 | Ensign et al. | Apr 2002 | B1 |
6406497 | Takei et al. | Jun 2002 | B2 |
6413279 | Metzger et al. | Jul 2002 | B1 |
6428577 | Evans | Aug 2002 | B1 |
6436145 | Miller | Aug 2002 | B1 |
6491726 | Pappas | Dec 2002 | B2 |
6506215 | Letot et al. | Jan 2003 | B1 |
6506216 | McCue et al. | Jan 2003 | B1 |
6558426 | Masini | May 2003 | B1 |
6607559 | Ralph et al. | Aug 2003 | B2 |
6623526 | Lloyd | Sep 2003 | B1 |
6632225 | Sanford et al. | Oct 2003 | B2 |
6660039 | Evans et al. | Dec 2003 | B1 |
6702821 | Bonutti | Mar 2004 | B2 |
6709461 | O'neil et al. | Mar 2004 | B2 |
6743258 | Keller | Jun 2004 | B1 |
6755864 | Brack et al. | Jun 2004 | B1 |
6770078 | Bonutti | Aug 2004 | B2 |
6869448 | Tuke | Mar 2005 | B2 |
6923832 | Sharkey et al. | Aug 2005 | B1 |
6942670 | Heldreth et al. | Sep 2005 | B2 |
6953479 | Carson et al. | Oct 2005 | B2 |
6974481 | Carson | Dec 2005 | B1 |
6986791 | Metzger | Jan 2006 | B1 |
7025788 | Metzger et al. | Apr 2006 | B2 |
7060074 | Rosa et al. | Jun 2006 | B2 |
7081137 | Servidio | Jul 2006 | B1 |
7083652 | McCue et al. | Aug 2006 | B2 |
7153326 | Metzger | Dec 2006 | B1 |
7160330 | Axelson, Jr. et al. | Jan 2007 | B2 |
7189262 | Hayes, Jr. et al. | Mar 2007 | B2 |
7261740 | Tuttle | Aug 2007 | B2 |
7264635 | Suguro | Sep 2007 | B2 |
7294149 | Hozack et al. | Nov 2007 | B2 |
7309362 | Yasuda et al. | Dec 2007 | B2 |
7309363 | Dietz | Dec 2007 | B2 |
7326252 | Otto et al. | Feb 2008 | B2 |
7351263 | Afriat | Apr 2008 | B2 |
7364581 | Michalowicz | Apr 2008 | B2 |
7412897 | Crottet et al. | Aug 2008 | B2 |
7413577 | Servidio | Aug 2008 | B1 |
7442196 | Fisher et al. | Oct 2008 | B2 |
7445639 | Metzger et al. | Nov 2008 | B2 |
7488330 | Stad | Feb 2009 | B2 |
7497874 | Metzger et al. | Mar 2009 | B1 |
7513912 | Hayes, Jr. et al. | Apr 2009 | B2 |
7544211 | Rochetin | Jun 2009 | B2 |
7547327 | Collazo | Jun 2009 | B2 |
7575602 | Amirouche et al. | Aug 2009 | B2 |
7578821 | Fisher et al. | Aug 2009 | B2 |
7585328 | Haas | Sep 2009 | B2 |
7587945 | Crottet et al. | Sep 2009 | B2 |
7591854 | Wasielewski | Sep 2009 | B2 |
7625407 | Akizuki | Dec 2009 | B2 |
7628818 | Hazebrouck et al. | Dec 2009 | B2 |
7632283 | Heldreth | Dec 2009 | B2 |
7632314 | Dietz | Dec 2009 | B2 |
7635390 | Bonutti | Dec 2009 | B1 |
7678152 | Suguro et al. | Mar 2010 | B2 |
7695519 | Collazo | Apr 2010 | B2 |
7695520 | Metzger et al. | Apr 2010 | B2 |
7776085 | Bernero et al. | Aug 2010 | B2 |
7837691 | Cordes et al. | Nov 2010 | B2 |
7850698 | Straszheim-Morley et al. | Dec 2010 | B2 |
8012216 | Metzger | Sep 2011 | B2 |
8065927 | Crottet et al. | Nov 2011 | B2 |
8141437 | Amirouche et al. | Mar 2012 | B2 |
8163028 | Metzger et al. | Apr 2012 | B2 |
8187280 | May et al. | May 2012 | B2 |
8197549 | Amirouche et al. | Jun 2012 | B2 |
8211041 | Fisher et al. | Jul 2012 | B2 |
8245583 | Stein | Aug 2012 | B2 |
8268006 | Meyers et al. | Sep 2012 | B2 |
8317870 | Wagner et al. | Nov 2012 | B2 |
8328873 | Metzger et al. | Dec 2012 | B2 |
8366782 | Wright | Feb 2013 | B2 |
8491589 | Fisher et al. | Jul 2013 | B2 |
8506571 | Chana et al. | Aug 2013 | B2 |
RE44476 | Meyers et al. | Sep 2013 | E |
8568486 | Wentorf et al. | Oct 2013 | B2 |
8574304 | Wentorf et al. | Nov 2013 | B2 |
8591594 | Parisi et al. | Nov 2013 | B2 |
8603101 | Claypool et al. | Dec 2013 | B2 |
8613775 | Wentorf et al. | Dec 2013 | B2 |
8617250 | Metzger | Dec 2013 | B2 |
8628580 | Sanford et al. | Jan 2014 | B2 |
8690954 | Parisi et al. | Apr 2014 | B2 |
8740984 | Hartdegen et al. | Jun 2014 | B2 |
8758444 | Wentorf et al. | Jun 2014 | B2 |
8764838 | Parisi et al. | Jul 2014 | B2 |
8764840 | Sanford et al. | Jul 2014 | B2 |
8795282 | Earl et al. | Aug 2014 | B2 |
8808387 | Hawkins et al. | Aug 2014 | B2 |
8858643 | Parisi et al. | Oct 2014 | B2 |
8932298 | Colquhoun et al. | Jan 2015 | B2 |
8932365 | Parisi et al. | Jan 2015 | B2 |
8979847 | Belcher et al. | Mar 2015 | B2 |
8979936 | White et al. | Mar 2015 | B2 |
8998997 | Ries et al. | Apr 2015 | B2 |
9011459 | Claypool et al. | Apr 2015 | B2 |
9072607 | Parisi et al. | Jul 2015 | B2 |
9131945 | Aram et al. | Sep 2015 | B2 |
9149206 | Claypool et al. | Oct 2015 | B2 |
9173744 | Donno et al. | Nov 2015 | B2 |
9186255 | Parisi | Nov 2015 | B2 |
9192480 | Wentorf et al. | Nov 2015 | B2 |
9204970 | Parisi et al. | Dec 2015 | B2 |
9283082 | Sanford et al. | Mar 2016 | B2 |
9295557 | Wentorf et al. | Mar 2016 | B2 |
9295558 | Parisi et al. | Mar 2016 | B2 |
9308095 | Parisi et al. | Apr 2016 | B2 |
9308096 | Wentorf et al. | Apr 2016 | B2 |
9314343 | Parisi et al. | Apr 2016 | B2 |
9381090 | Wentorf et al. | Jul 2016 | B2 |
9427337 | Claypool et al. | Aug 2016 | B2 |
9492290 | Claypool et al. | Nov 2016 | B2 |
9539116 | Claypool | Jan 2017 | B2 |
9592133 | Toler et al. | Mar 2017 | B2 |
9597090 | Claypool et al. | Mar 2017 | B2 |
9655728 | Parisi et al. | May 2017 | B2 |
9655729 | Parisi et al. | May 2017 | B2 |
9707089 | Grey et al. | Jul 2017 | B2 |
9763794 | Sanford et al. | Sep 2017 | B2 |
9763795 | Parisi et al. | Sep 2017 | B2 |
9763796 | Wentorf et al. | Sep 2017 | B2 |
9763807 | Claypool et al. | Sep 2017 | B2 |
9788954 | Parisi et al. | Oct 2017 | B2 |
9861490 | Wentorf et al. | Jan 2018 | B2 |
9901331 | Toler et al. | Feb 2018 | B2 |
9918844 | Sanford et al. | Mar 2018 | B2 |
9925050 | Parisi et al. | Mar 2018 | B2 |
9925052 | Dai | Mar 2018 | B2 |
10010330 | Claypool et al. | Jul 2018 | B2 |
10092407 | Faccioli et al. | Oct 2018 | B2 |
10188530 | Claypool et al. | Jan 2019 | B2 |
10195041 | Wentorf et al. | Feb 2019 | B2 |
10265181 | Wentorf et al. | Apr 2019 | B2 |
10278827 | Drury et al. | May 2019 | B2 |
10413415 | Parisi et al. | Sep 2019 | B2 |
10470889 | Wentorf et al. | Nov 2019 | B2 |
10500054 | Croll | Dec 2019 | B2 |
10543099 | Sanford et al. | Jan 2020 | B2 |
10575956 | Dai et al. | Mar 2020 | B2 |
10675153 | Byrd et al. | Jun 2020 | B2 |
10835380 | Drury et al. | Nov 2020 | B2 |
10898337 | Parisi et al. | Jan 2021 | B2 |
11160659 | Drury et al. | Nov 2021 | B2 |
20010004721 | Wolf | Nov 2001 | A1 |
20020058997 | O'connor et al. | May 2002 | A1 |
20020072802 | O'Neil et al. | Jun 2002 | A1 |
20020120340 | Metzger et al. | Aug 2002 | A1 |
20020161448 | Hayes, Jr. et al. | Oct 2002 | A1 |
20030055509 | Mccue et al. | Mar 2003 | A1 |
20030199985 | Masini | Oct 2003 | A1 |
20040019382 | Amirouche et al. | Jan 2004 | A1 |
20040019383 | Beguec | Jan 2004 | A1 |
20040034432 | Hughes et al. | Feb 2004 | A1 |
20040059340 | Serra et al. | Mar 2004 | A1 |
20040064191 | Wasielewski | Apr 2004 | A1 |
20040122441 | Muratsu | Jun 2004 | A1 |
20040153066 | Coon et al. | Aug 2004 | A1 |
20040162620 | Wyss | Aug 2004 | A1 |
20040167537 | Errico et al. | Aug 2004 | A1 |
20040186582 | Yasuda et al. | Sep 2004 | A1 |
20040204765 | Fenning et al. | Oct 2004 | A1 |
20040225368 | Plumet et al. | Nov 2004 | A1 |
20040236429 | Ensign et al. | Nov 2004 | A1 |
20040243244 | Otto et al. | Dec 2004 | A1 |
20040267371 | Hayes, Jr. et al. | Dec 2004 | A1 |
20050055102 | Tornier et al. | Mar 2005 | A1 |
20050096747 | Tuttle et al. | May 2005 | A1 |
20050143831 | Justin et al. | Jun 2005 | A1 |
20050143832 | Carson | Jun 2005 | A1 |
20050177170 | Fisher et al. | Aug 2005 | A1 |
20050019771 | Naegerl | Sep 2005 | A1 |
20050209701 | Suguro et al. | Sep 2005 | A1 |
20050209702 | Todd et al. | Sep 2005 | A1 |
20050246030 | Yao | Nov 2005 | A1 |
20050267485 | Cordes et al. | Dec 2005 | A1 |
20050267584 | Burdulis et al. | Dec 2005 | A1 |
20050278035 | Wyss et al. | Dec 2005 | A1 |
20060004460 | Engh et al. | Jan 2006 | A1 |
20060020343 | Ek | Jan 2006 | A1 |
20060030945 | Wright | Feb 2006 | A1 |
20060052782 | Morgan et al. | Mar 2006 | A1 |
20060069436 | Sutton et al. | Mar 2006 | A1 |
20060089653 | Auger et al. | Apr 2006 | A1 |
20060142869 | Gross | Jun 2006 | A1 |
20060161259 | Cheng et al. | Jul 2006 | A1 |
20060184176 | Straszheim-Morley et al. | Aug 2006 | A1 |
20060189864 | Paradis et al. | Aug 2006 | A1 |
20060190087 | O'Connor | Aug 2006 | A1 |
20060195195 | Burstein et al. | Aug 2006 | A1 |
20060111726 | Felt et al. | Oct 2006 | A1 |
20060224244 | Thomas et al. | Oct 2006 | A1 |
20060265080 | Mcminn | Nov 2006 | A1 |
20070010890 | Collazo | Jan 2007 | A1 |
20070123992 | Sanford | May 2007 | A1 |
20070129808 | Justin et al. | Jun 2007 | A1 |
20070135924 | Verhoogen | Jun 2007 | A1 |
20070135926 | Walker | Jun 2007 | A1 |
20070185581 | Akizuki et al. | Aug 2007 | A1 |
20070198022 | Lang et al. | Aug 2007 | A1 |
20070233269 | Steines et al. | Oct 2007 | A1 |
20070234819 | Amirouche et al. | Oct 2007 | A1 |
20070239165 | Amirouche | Oct 2007 | A1 |
20080021566 | Peters et al. | Jan 2008 | A1 |
20080051908 | Angibaud et al. | Feb 2008 | A1 |
20080058947 | Earl et al. | Mar 2008 | A1 |
20080058948 | Biegun et al. | Mar 2008 | A1 |
20080091271 | Bonitati et al. | Apr 2008 | A1 |
20080091272 | Aram et al. | Apr 2008 | A1 |
20080091273 | Hazebrouck | Apr 2008 | A1 |
20080103603 | Hintermann | May 2008 | A1 |
20080114462 | Guidera et al. | May 2008 | A1 |
20080119938 | Oh | May 2008 | A1 |
20080119940 | Otto et al. | May 2008 | A1 |
20080140212 | Metzger et al. | Jun 2008 | A1 |
20080161918 | Fankhauser et al. | Jul 2008 | A1 |
20080167722 | Metzger et al. | Jul 2008 | A1 |
20080215156 | Duggal et al. | Sep 2008 | A1 |
20080243258 | Sancheti | Oct 2008 | A1 |
20080262624 | White et al. | Oct 2008 | A1 |
20080281426 | Fitz et al. | Nov 2008 | A1 |
20080288080 | Sancheti | Nov 2008 | A1 |
20080300689 | Mc Kinnon et al. | Dec 2008 | A1 |
20080300690 | Burstein et al. | Dec 2008 | A1 |
20090005708 | Johanson et al. | Jan 2009 | A1 |
20090036992 | Tsakonas | Feb 2009 | A1 |
20090043395 | Hotokebuchi et al. | Feb 2009 | A1 |
20090062806 | Scott et al. | Mar 2009 | A1 |
20090082873 | Hazebrouck et al. | Mar 2009 | A1 |
20090088862 | Thomas et al. | Apr 2009 | A1 |
20090125114 | May et al. | May 2009 | A1 |
20090149963 | Sekel | Jun 2009 | A1 |
20090149964 | May et al. | Jun 2009 | A1 |
20090204221 | Walker | Aug 2009 | A1 |
20090204222 | Burstein et al. | Aug 2009 | A1 |
20090210066 | Jasty | Aug 2009 | A1 |
20090222103 | Fitz et al. | Sep 2009 | A1 |
20090259314 | Linder-ganz et al. | Oct 2009 | A1 |
20090264894 | Wasielewski | Oct 2009 | A1 |
20090265011 | Mandell | Oct 2009 | A1 |
20090265013 | Mandell | Oct 2009 | A1 |
20090028731 | Fisher et al. | Nov 2009 | A1 |
20090306786 | Samuelson | Dec 2009 | A1 |
20090306787 | Crabtree et al. | Dec 2009 | A1 |
20090319047 | Walker | Dec 2009 | A1 |
20090319048 | Shah et al. | Dec 2009 | A1 |
20090319049 | Shah et al. | Dec 2009 | A1 |
20090326663 | Dun | Dec 2009 | A1 |
20090326665 | Wyss et al. | Dec 2009 | A1 |
20090326666 | Wyss et al. | Dec 2009 | A1 |
20090326668 | Dun | Dec 2009 | A1 |
20100010494 | Quirno | Jan 2010 | A1 |
20100016976 | Siebel | Jan 2010 | A1 |
20100016977 | Masini | Jan 2010 | A1 |
20100016978 | Williams et al. | Jan 2010 | A1 |
20100016979 | Wyss et al. | Jan 2010 | A1 |
20100036499 | Pinskerova | Feb 2010 | A1 |
20100036500 | Heldreth et al. | Feb 2010 | A1 |
20100063594 | Hazebrouck et al. | Mar 2010 | A1 |
20100063595 | Dietz | Mar 2010 | A1 |
20100076563 | Otto et al. | Mar 2010 | A1 |
20100082111 | Thomas | Apr 2010 | A1 |
20100100011 | Roche | Apr 2010 | A1 |
20100100189 | Metzger | Apr 2010 | A1 |
20100100191 | May et al. | Apr 2010 | A1 |
20100125339 | Earl et al. | May 2010 | A1 |
20100152858 | Lu et al. | Jun 2010 | A1 |
20100191298 | Earl et al. | Jul 2010 | A1 |
20100191341 | Byrd | Jul 2010 | A1 |
20100198275 | Chana et al. | Aug 2010 | A1 |
20100222890 | Barnett et al. | Sep 2010 | A1 |
20100249660 | Sherman et al. | Sep 2010 | A1 |
20100249789 | Rock et al. | Sep 2010 | A1 |
20100262253 | Cipolletti et al. | Oct 2010 | A1 |
20100286788 | Komistek | Nov 2010 | A1 |
20100292804 | Samuelson | Nov 2010 | A1 |
20100305708 | Lang | Dec 2010 | A1 |
20100329530 | Lang et al. | Dec 2010 | A1 |
20110022179 | Andriacchi et al. | Jan 2011 | A1 |
20110029091 | Bojarski et al. | Feb 2011 | A1 |
20110040387 | Ries et al. | Feb 2011 | A1 |
20110066246 | Ries et al. | Mar 2011 | A1 |
20110082558 | Kim et al. | Apr 2011 | A1 |
20110082559 | Hartdegen et al. | Apr 2011 | A1 |
20110087332 | Bojarski et al. | Apr 2011 | A1 |
20110098824 | Jukes et al. | Apr 2011 | A1 |
20110100011 | Staffend | May 2011 | A1 |
20110125278 | Bercovy et al. | May 2011 | A1 |
20110144760 | Wong et al. | Jun 2011 | A1 |
20110153026 | Heggendorn et al. | Jun 2011 | A1 |
20110190898 | Lenz et al. | Aug 2011 | A1 |
20110202139 | Metzger et al. | Aug 2011 | A1 |
20110251695 | Lenz et al. | Oct 2011 | A1 |
20120022658 | Wentorf | Jan 2012 | A1 |
20120022659 | Wentorf | Jan 2012 | A1 |
20120022660 | Wentorf | Jan 2012 | A1 |
20120035735 | Sanford et al. | Feb 2012 | A1 |
20120035737 | Sanford | Feb 2012 | A1 |
20120095563 | Sanford et al. | Apr 2012 | A1 |
20120101585 | Parisi et al. | Apr 2012 | A1 |
20120158152 | Claypool et al. | Jun 2012 | A1 |
20120179069 | Amirouche | Jul 2012 | A1 |
20120185054 | Maloney et al. | Jul 2012 | A1 |
20120185055 | Maloney et al. | Jul 2012 | A1 |
20120232429 | Fischer et al. | Sep 2012 | A1 |
20120290088 | Amirouche et al. | Nov 2012 | A1 |
20120296437 | Wyss et al. | Nov 2012 | A1 |
20120310246 | Belcher et al. | Dec 2012 | A1 |
20120310361 | Zubok et al. | Dec 2012 | A1 |
20120323335 | Parisi et al. | Dec 2012 | A1 |
20120323336 | Parisi et al. | Dec 2012 | A1 |
20130013076 | Fisher et al. | Jan 2013 | A1 |
20130024001 | Wentorf et al. | Jan 2013 | A1 |
20130079671 | Stein et al. | Mar 2013 | A1 |
20130096567 | Fisher et al. | Apr 2013 | A1 |
20130102929 | Haight et al. | Apr 2013 | A1 |
20130103038 | Fischer et al. | Apr 2013 | A1 |
20130131816 | Parisi et al. | May 2013 | A1 |
20130131817 | Parisi et al. | May 2013 | A1 |
20130131818 | Parisi et al. | May 2013 | A1 |
20130131819 | Parisi et al. | May 2013 | A1 |
20130131820 | Wentorf et al. | May 2013 | A1 |
20130017301 | Irwin | Jul 2013 | A1 |
20130226305 | Donno et al. | Aug 2013 | A1 |
20130253378 | Claypool et al. | Sep 2013 | A1 |
20130261504 | Claypool et al. | Oct 2013 | A1 |
20130261757 | Claypool et al. | Oct 2013 | A1 |
20130261758 | Claypool et al. | Oct 2013 | A1 |
20130345820 | Maloney et al. | Dec 2013 | A1 |
20140025175 | Wentorf et al. | Jan 2014 | A1 |
20140025176 | Wentorf | Jan 2014 | A1 |
20140025177 | Wentorf et al. | Jan 2014 | A1 |
20140052268 | Sanford et al. | Feb 2014 | A1 |
20140052269 | Claypool et al. | Feb 2014 | A1 |
20140156015 | Parisi et al. | Jun 2014 | A1 |
20140163687 | Parisi et al. | Jun 2014 | A1 |
20140249641 | Wentorf et al. | Sep 2014 | A1 |
20140257505 | Parisi et al. | Sep 2014 | A1 |
20140257506 | Sanford et al. | Sep 2014 | A1 |
20140296859 | Claypool et al. | Oct 2014 | A1 |
20150005890 | Parisi et al. | Jan 2015 | A1 |
20150025644 | Heggendorn et al. | Jan 2015 | A1 |
20150066150 | Dai et al. | Mar 2015 | A1 |
20150088140 | Toler et al. | Mar 2015 | A1 |
20150190243 | Claypool et al. | Jul 2015 | A1 |
20150282936 | Parisi et al. | Oct 2015 | A1 |
20150320564 | Parisi et al. | Nov 2015 | A1 |
20150359642 | Claypool et al. | Dec 2015 | A1 |
20160030053 | Yager et al. | Feb 2016 | A1 |
20160038294 | Parisi et al. | Feb 2016 | A1 |
20160045322 | Parisi et al. | Feb 2016 | A1 |
20160135959 | Sanford et al. | May 2016 | A1 |
20160158019 | Grey et al. | Jun 2016 | A1 |
20160184107 | Parisi et al. | Jun 2016 | A1 |
20160287397 | Wentorf | Oct 2016 | A1 |
20160324647 | Claypool et al. | Nov 2016 | A1 |
20170079801 | Drury et al. | Mar 2017 | A1 |
20170143324 | Toler et al. | May 2017 | A1 |
20170156736 | Claypool et al. | Jun 2017 | A1 |
20170231773 | Lu | Aug 2017 | A1 |
20170266011 | Wentorf et al. | Sep 2017 | A1 |
20170281354 | Soffiatti et al. | Oct 2017 | A1 |
20180000601 | Sanford et al. | Jan 2018 | A1 |
20180000602 | Wentorf et al. | Jan 2018 | A1 |
20180000612 | Claypool et al. | Jan 2018 | A1 |
20180021143 | Parisi et al. | Jan 2018 | A1 |
20180021144 | Parisi et al. | Jan 2018 | A1 |
20180085225 | Wentorf et al. | Mar 2018 | A1 |
20180161166 | Dai et al. | Jun 2018 | A1 |
20180256346 | Byrd et al. | Sep 2018 | A1 |
20180325684 | Croll | Nov 2018 | A1 |
20190142594 | Yager | May 2019 | A1 |
20190209333 | Drury et al. | Jul 2019 | A1 |
20190328535 | Drury et al. | Oct 2019 | A1 |
20190350718 | Parisi et al. | Nov 2019 | A1 |
20200030106 | Wentorf et al. | Jan 2020 | A1 |
20200113702 | Sanford et al. | Apr 2020 | A1 |
20200146830 | Dai et al. | May 2020 | A1 |
20200237518 | Byrd et al. | Jul 2020 | A1 |
20210022875 | Drury et al. | Jan 2021 | A1 |
20210113340 | Parisi et al. | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
2011343440 | Apr 2014 | AU |
2011286306 | Oct 2014 | AU |
2190029 | Nov 1995 | CA |
2856070 | Jul 2016 | CA |
687584 | Jan 1997 | CH |
1087506 | Jun 1994 | CN |
1174498 | Feb 1998 | CN |
1179709 | Apr 1998 | CN |
1440262 | Sep 2003 | CN |
1549695 | Nov 2004 | CN |
2768715 | Apr 2006 | CN |
1780594 | May 2006 | CN |
1874738 | Dec 2006 | CN |
101214175 | Jul 2008 | CN |
101222886 | Jul 2008 | CN |
101288597 | Oct 2008 | CN |
101347359 | Jan 2009 | CN |
201175391 | Jan 2009 | CN |
101361684 | Feb 2009 | CN |
101401750 | Apr 2009 | CN |
101426453 | May 2009 | CN |
101522136 | Sep 2009 | CN |
101646392 | Feb 2010 | CN |
101658446 | Mar 2010 | CN |
101683289 | Mar 2010 | CN |
101711701 | May 2010 | CN |
101795643 | Aug 2010 | CN |
101835441 | Sep 2010 | CN |
102018584 | Apr 2011 | CN |
102048594 | May 2011 | CN |
102058446 | May 2011 | CN |
102058448 | May 2011 | CN |
102917670 | Feb 2013 | CN |
103118634 | May 2013 | CN |
103118635 | May 2013 | CN |
103118636 | May 2013 | CN |
103370025 | Oct 2013 | CN |
103379880 | Oct 2013 | CN |
103732186 | Apr 2014 | CN |
104039273 | Sep 2014 | CN |
104066402 | Sep 2014 | CN |
104093380 | Oct 2014 | CN |
104135969 | Nov 2014 | CN |
104203160 | Dec 2014 | CN |
104321263 | Jan 2015 | CN |
104379094 | Feb 2015 | CN |
104736105 | Jun 2015 | CN |
105055052 | Nov 2015 | CN |
105167889 | Dec 2015 | CN |
103118634 | Aug 2016 | CN |
103118636 | Aug 2016 | CN |
104093380 | Aug 2016 | CN |
103370025 | Nov 2016 | CN |
106073949 | Nov 2016 | CN |
106214292 | Dec 2016 | CN |
108135701 | Jun 2018 | CN |
106073949 | Dec 2018 | CN |
109310504 | Feb 2019 | CN |
110022798 | Jul 2019 | CN |
110402123 | Nov 2019 | CN |
113317912 | Aug 2021 | CN |
0021421 | Jan 1981 | EP |
0303467 | Feb 1989 | EP |
0327495 | Aug 1989 | EP |
0340919 | Nov 1989 | EP |
340919 | Nov 1989 | EP |
0372811 | Jun 1990 | EP |
0306744 | Apr 1992 | EP |
0495340 | Jul 1992 | EP |
0636353 | Feb 1995 | EP |
0672397 | Sep 1995 | EP |
0552950 | Sep 1996 | EP |
0536457 | Jan 1997 | EP |
0642328 | Dec 1998 | EP |
0592750 | Jan 1999 | EP |
0903125 | Mar 1999 | EP |
0956836 | Nov 1999 | EP |
0956836 | Nov 1999 | EP |
1025818 | Aug 2000 | EP |
1097679 | May 2001 | EP |
0709074 | Dec 2002 | EP |
1327424 | Jul 2003 | EP |
1378216 | Jan 2004 | EP |
1477143 | Nov 2004 | EP |
1568336 | Aug 2005 | EP |
1719478 | Nov 2006 | EP |
1722721 | Nov 2006 | EP |
1354571 | Jun 2007 | EP |
1396240 | Apr 2008 | EP |
1604623 | Jun 2008 | EP |
1996122 | Dec 2008 | EP |
0927009 | Jan 2009 | EP |
2011455 | Jan 2009 | EP |
1696835 | Feb 2009 | EP |
1132063 | Sep 2009 | EP |
1591082 | Sep 2009 | EP |
2140838 | Jan 2010 | EP |
2140839 | Jan 2010 | EP |
2143403 | Jan 2010 | EP |
2237177 | Oct 2010 | EP |
1555962 | Feb 2011 | EP |
2319460 | May 2011 | EP |
2324799 | May 2011 | EP |
2335654 | Jun 2011 | EP |
2347733 | Jul 2011 | EP |
0689808 | Sep 2012 | EP |
2595573 | May 2013 | EP |
2782525 | Oct 2014 | EP |
2830543 | Feb 2015 | EP |
2830544 | Feb 2015 | EP |
2830544 | Sep 2016 | EP |
2918235 | Jan 2017 | EP |
3143964 | Mar 2017 | EP |
2595574 | May 2017 | EP |
3111894 | Dec 2018 | EP |
2728782 | Jul 1996 | FR |
2736819 | Jan 1997 | FR |
2747914 | Oct 1997 | FR |
2778332 | Nov 1999 | FR |
2788964 | Aug 2000 | FR |
2824260 | Nov 2002 | FR |
2852819 | Oct 2004 | FR |
2926719 | Jul 2009 | FR |
225347 | Dec 1924 | GB |
2253147 | Sep 1992 | GB |
2345446 | Jul 2000 | GB |
7145DELNP2014 | Apr 2015 | IN |
61247449 | Nov 1986 | JP |
62270153 | Nov 1987 | JP |
06203576 | Jul 1994 | JP |
09289998 | Nov 1997 | JP |
09511668 | Nov 1997 | JP |
2000000255 | Jan 2000 | JP |
2000245758 | Sep 2000 | JP |
2003516183 | May 2003 | JP |
2004166802 | Jun 2004 | JP |
2004254811 | Sep 2004 | JP |
3734270 | Jan 2006 | JP |
2007054488 | Mar 2007 | JP |
2007509709 | Apr 2007 | JP |
2007222616 | Sep 2007 | JP |
2009082713 | Apr 2009 | JP |
2009245619 | Oct 2009 | JP |
2010022827 | Feb 2010 | JP |
2010188051 | Sep 2010 | JP |
2010240406 | Oct 2010 | JP |
2010259808 | Nov 2010 | JP |
2011092738 | May 2011 | JP |
2012500667 | Jan 2012 | JP |
2012531265 | Dec 2012 | JP |
2015512307 | Apr 2013 | JP |
2013535276 | Sep 2013 | JP |
2013536005 | Sep 2013 | JP |
2013536006 | Sep 2013 | JP |
2013536007 | Sep 2013 | JP |
2014505517 | Mar 2014 | JP |
2014508554 | Apr 2014 | JP |
2014522292 | Sep 2014 | JP |
2014239900 | Dec 2014 | JP |
2015502203 | Jan 2015 | JP |
2015504333 | Feb 2015 | JP |
2015504759 | Feb 2015 | JP |
2015513966 | May 2015 | JP |
2015231566 | Dec 2015 | JP |
2016028729 | Mar 2016 | JP |
5980341 | Aug 2016 | JP |
2016195841 | Nov 2016 | JP |
2017221732 | Dec 2017 | JP |
2021142355 | Sep 2021 | JP |
WO-9305729 | Apr 1993 | WO |
WO-9409725 | May 1994 | WO |
WO-9514444 | Jun 1995 | WO |
WO-9514446 | Jun 1995 | WO |
WO-9530389 | Nov 1995 | WO |
WO-9535074 | Dec 1995 | WO |
WO-9934755 | Jul 1999 | WO |
WO-0141680 | Jun 2001 | WO |
WO-200141680 | Jun 2001 | WO |
WO-03099106 | Dec 2003 | WO |
WO-2004058108 | Jul 2004 | WO |
WO-2005037147 | Apr 2005 | WO |
WO-2005051240 | Jun 2005 | WO |
WO-2005122967 | Dec 2005 | WO |
WO-2006058057 | Jun 2006 | WO |
WO-2006092167 | Sep 2006 | WO |
WO-2007108804 | Sep 2007 | WO |
WO-2007109641 | Sep 2007 | WO |
WO-2007119173 | Oct 2007 | WO |
WO-2009029631 | Mar 2009 | WO |
WO-2009088235 | Jul 2009 | WO |
WO-2009088236 | Jul 2009 | WO |
WO-2009088238 | Jul 2009 | WO |
WO-2009105495 | Aug 2009 | WO |
WO-2010001010 | Jan 2010 | WO |
WO-2010008803 | Jan 2010 | WO |
WO-2010011590 | Jan 2010 | WO |
WO-2010022272 | Feb 2010 | WO |
WO-2010023062 | Mar 2010 | WO |
WO-2010045537 | Apr 2010 | WO |
WO-2010075365 | Jul 2010 | WO |
WO-2011043955 | Apr 2011 | WO |
WO-2011063123 | May 2011 | WO |
WO-201 1072235 | Jun 2011 | WO |
WO-2011071979 | Jun 2011 | WO |
WO-2011110865 | Sep 2011 | WO |
WO-2012004580 | Jan 2012 | WO |
WO-2012018563 | Feb 2012 | WO |
WO-2012018564 | Feb 2012 | WO |
WO-2012018565 | Feb 2012 | WO |
WO-2012018566 | Feb 2012 | WO |
WO-2012018567 | Feb 2012 | WO |
WO-2012020460 | Feb 2012 | WO |
WO-2012082628 | Jun 2012 | WO |
WO-2012083280 | Jun 2012 | WO |
WO-2012112698 | Aug 2012 | WO |
WO-2012173706 | Dec 2012 | WO |
WO-2013003433 | Jan 2013 | WO |
WO-2013013094 | Jan 2013 | WO |
WO-2013074142 | May 2013 | WO |
WO-2013074143 | May 2013 | WO |
WO-2013074144 | May 2013 | WO |
WO-2013074145 | May 2013 | WO |
WO-2013077919 | May 2013 | WO |
WO-2013115849 | Aug 2013 | WO |
WO-2013148954 | Oct 2013 | WO |
WO-2013148960 | Oct 2013 | WO |
WO-2017053196 | Mar 2017 | WO |
WO-2018165442 | Sep 2018 | WO |
WO-2018208612 | Nov 2018 | WO |
Entry |
---|
“U.S. Appl. No. 15/971,743, Notice of Allowance dated Aug. 6, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2018/031177, International Search Report dated Jul. 31, 2018”, 6 pgs. |
“International Application Serial No. PCT/US2018/031177, Written Opinion dated Jul. 31, 2018”, 6 pgs. |
“U.S. Appl. No. 13/087,610, Non Final Office Action dated Feb. 26, 2013”, 7 pgs. |
“U.S. Appl. No. 13/087,610, Notice of Allowance dated Jun. 28, 2013”, 6 pgs. |
“U.S. Appl. No. 13/087,610, Notice of Allowance dated Oct. 8, 2013”, 7 pgs. |
“U.S. Appl. No. 13/087,610, Response filed May 24, 2013 to Non Final Office Action dated Feb. 26, 2013”, 15 pgs. |
“U.S. Appl. No. 13/189,324, Examiner Interview Summary dated Jan. 13, 2014”, 4 pgs. |
“U.S. Appl. No. 13/189,324, Final Office Action dated Jul. 16, 2013”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Non Final Office Action dated Dec. 11, 2012”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Notice of Allowance dated Feb. 20, 2014”, 8 pgs. |
“U.S. Appl. No. 13/189,324, PTO Response to 312 Amendment dated May 29, 2014”, 2 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jan. 15, 2014 to Final Office Action dated Jul. 16, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jun. 10, 2013 to Non Final Office Action dated Dec. 11, 2012”, 24 pgs. |
“U.S. Appl. No. 13/189,328, Non Final Office Action dated Mar. 19, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,328, Notice of Allowance dated Oct. 8, 2013”, 12 pgs. |
“U.S. Appl. No. 13/189,328, PTO Response to 312 Amendment dated Dec. 13, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jan. 10, 2013 to Restriction Requirement dated Dec. 10, 2012”, 9 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jul. 18, 2013 to Non Final Office Action dated Mar. 19, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,328, Restriction Requirement dated Dec. 10, 2012”, 6 pgs. |
“U.S. Appl. No. 13/189,336, Notice of Allowance dated Sep. 13, 2013”, 30 pgs. |
“U.S. Appl. No. 13/189,336, PTO Response to 312 Amendment dated Nov. 25, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Apr. 15, 2013 to Restriction Requirement dated Jan. 30, 2013”, 21 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 20 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement dated Jan. 30, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement dated Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,338, Notice of Allowance dated Sep. 23, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Apr. 15, 2013 to Restriction Requirement dated Feb. 14, 2013”, 18 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement dated Feb. 14, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement dated Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Notice of Allowance dated Sep. 20, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Apr. 15, 2013 to Restriction Requirement dated Mar. 6, 2013”, 11 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement dated Mar. 6, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement dated Jun. 17, 2013”, 7 pgs. |
“U.S. Appl. No. 13/229,103, Applicant Interview Summary dated Sep. 23, 2013”, 2 pgs. |
“U.S. Appl. No. 13/229,103, Examiner Interview Summary dated Sep. 13, 2013”, 3 pgs. |
“U.S. Appl. No. 13/229,103, Non Final Office Action dated Apr. 1, 2013”, 18 pgs. |
“U.S. Appl. No. 13/229,103, Notice of Allowance dated Sep. 18, 2013”, 9 pgs. |
“U.S. Appl. No. 13/229,103, Response filed Jul. 1, 2013 to Non Final Office Action dated Apr. 1, 2013”, 19 pgs. |
“U.S. Appl. No. 13/229,103, Supplemental Notice of Allowability dated Oct. 18, 2013”, 2 pgs. |
“U.S. Appl. No. 13/459,037, Final Office Action dated Sep. 23, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Non Final Office Action dated Apr. 23, 2013”, 10 pgs. |
“U.S. Appl. No. 13/459,037, Notice of Allowance dated Jun. 13, 2014”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Preliminary Amendment filed Apr. 27, 2012”, 3 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Mar. 21, 2014 to Final Office Action dated Sep. 23, 2013”, 15 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Mar. 28, 2013 to Restriction Requirement dated Feb. 26, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Jul. 23, 2013 to Non Final Office Action dated Apr. 23, 2013”, 19 pgs. |
“U.S. Appl. No. 13/459,037, Restriction Requirement dated Feb. 26, 2013”, 6 pgs. |
“U.S. Appl. No. 13/459,041, Non Final Office Action dated Jan. 15, 2014”, 16 pgs. |
“U.S. Appl. No. 13/459,041, Non Final Office Action dated Sep. 9, 2014”, 14 pgs. |
“U.S. Appl. No. 13/459,041, Notice of Allowance dated Apr. 2, 2015”, 10 pgs. |
“U.S. Appl. No. 13/459,041, Preliminary Amendment dated Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,041, PTO Response to Rule 312 Communication dated Jun. 9, 2015”, 2 pgs. |
“U.S. Appl. No. 13/459,041, Response filed May 15, 2014 to Non-Final Office Action dated Jan. 15, 2014”, 24 pgs. |
“U.S. Appl. No. 13/459,041, Response filed Sep. 23, 2013 to Restriction Requirement dated Jul. 25, 2013”, 18 pgs. |
“U.S. Appl. No. 13/459,041, Response filed Dec. 9, 2014 to Non-Final Office Action dated Sep. 9, 2014”, 23 pgs. |
“U.S. Appl. No. 13/459,041, Restriction Requirement dated Jul. 25, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,048, Non Final Office Action dated Jul. 11, 2013”, 6 pgs. |
“U.S. Appl. No. 13/459,048, Notice of Allowance dated Nov. 26, 2013”, 10 pgs. |
“U.S. Appl. No. 13/459,048, Preliminary Amendment filed Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,048, Response filed Nov. 11, 2013 to Non-Final Office Action dated Jul. 11, 2013”, 16 pgs. |
“U.S. Appl. No. 13/459,056, Examiner Interview Summary dated Dec. 26, 2013”, 3 pgs. |
“U.S. Appl. No. 13/459,056, Non Final Office Action dated Jul. 25, 2013”, 11 pgs. |
“U.S. Appl. No. 13/459,056, Notice of Allowance dated Feb. 20, 2014”, 5 pgs. |
“U.S. Appl. No. 13/459,056, Preliminary Amendment filed Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,056, PTO Response to Rule 312 Communication dated May 22, 2014”, 2 pgs. |
“U.S. Appl. No. 13/459,056, Response filed Jan. 24, 2014 to Non-Final office Action dated Jul. 25, 2013”, 27 pgs. |
“U.S. Appl. No. 13/459,056, Response filed Apr. 8, 2013 to Restriction Requirement dated Mar. 6, 2013”, 15 pgs. |
“U.S. Appl. No. 13/459,056, Restriction Requirement dated Mar. 6, 2013”, 6 pgs. |
“U.S. Appl. No. 13/593,339, Non Final Office Action dated Oct. 4, 2013”, 7 pgs. |
“U.S. Appl. No. 13/593,339, Notice of Allowance dated Feb. 14, 2014”, 9 pgs. |
“U.S. Appl. No. 13/593,339, Preliminary Amendment filed Aug. 23, 2012”, 6 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Jan. 31, 2014 to Non-Final Office Action dated Oct. 4, 2013”, 19 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Aug. 30, 2013 to Restriction Requirement dated Aug. 1, 2013”, 14 pgs. |
“U.S. Appl. No. 13/593,339, Restriction Requirement dated Aug. 1, 2013”, 5 pgs. |
“U.S. Appl. No. 13/593,339, Supplemental Notice of Allowability dated Mar. 31, 2014”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Corrected Notice of Allowance dated Mar. 16, 2016”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Examiner Interview Summary dated Jan. 22, 2016”, 3 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action dated Jul. 17, 2014”, 12 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action dated Nov. 20, 2015”, 28 pgs. |
“U.S. Appl. No. 13/594,543, Non Final Office Action dated Jun. 19, 2015”, 30 pgs. |
“U.S. Appl. No. 13/594,543, Non Final Office Action dated Dec. 26, 2013”, 15 pgs. |
“U.S. Appl. No. 13/594,543, Non-Final Office Action dated Jan. 9, 2015”, 23 pgs. |
“U.S. Appl. No. 13/594,543, Notice of Allowance dated Mar. 1, 2016”, 9 pgs. |
“U.S. Appl. No. 13/594,543, Preliminary Amendment filed Aug. 24, 2012”, 4 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Feb. 8, 2016 to Final Office Action dated Nov. 20, 2015”, 17 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Apr. 7, 2015 to Non-Final Office Action dated Jan. 9, 2015”, 27 pgs. |
“U.S. Appl. No. 13/594,543, Response filed May 7, 2014 to Non-Final office Action dated Dec. 26, 2013”, 17 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Sep. 21, 2015 to Non-Final Office Action dated Jun. 19, 2015”, 25 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Oct. 11, 2013 to Restriction Requirement dated Sep. 12, 2013”, 8 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Dec. 17, 2014 to Final Office Action dated Jul. 17, 2014”, 15 pgs. |
“U.S. Appl. No. 13/594,543, Restriction Requirement dated Sep. 12, 2013”, 5 pgs. |
“U.S. Appl. No. 13/819,116, Advisory Action dated Jan. 5, 2016”, 3 pgs. |
“U.S. Appl. No. 13/819,116, Corrected Notice of Allowance dated Oct. 21, 2016”, 2 pgs. |
“U.S. Appl. No. 13/819,116, Examiner Interview Summary dated Apr. 18, 2016”, 11 pgs. |
“U.S. Appl. No. 13/819,116, Final Office Action dated Jul. 26, 2016”, 6 pgs. |
“U.S. Appl. No. 13/819,116, Final Office Action dated Oct. 21, 2015”, 15 pgs. |
“U.S. Appl. No. 13/819,116, Non Final Office Action dated Feb. 17, 2016”, 15 pgs. |
“U.S. Appl. No. 13/819,116, Non Final Office Action dated Jun. 2, 2015”, 14 pgs. |
“U.S. Appl. No. 13/819,116, Notice of Allowance dated Sep. 29, 2016”, 5 pgs. |
“U.S. Appl. No. 13/819,116, Preliminary Amendment filed Feb. 26, 2013”, 8 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Mar. 27, 2015 to Restriction Requirement dated Feb. 12, 2015”, 11 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Apr. 29, 2016 to Non Final Office Action dated Feb. 17, 2016”, 17 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Jul. 16, 2015 to Non Final Office Action dated Jun. 2, 2015”, 22 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Sep. 14, 2016 Final Office Action dated Jul. 26, 2016”, 10 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Dec. 15, 2015 to Final Office Action dated Oct. 21, 2015”, 16 pgs. |
“U.S. Appl. No. 13/819,116, Restriction Requirement dated Feb. 12, 2015”, 7 pgs. |
“U.S. Appl. No. 13/836,586, Express Abandonment filed May 30, 2014”, 1 pg. |
“U.S. Appl. No. 13/836,665, Examiner Interview Summary dated Jul. 17, 2014”, 4 pgs. |
“U.S. Appl. No. 13/836,665, Final Office Action dated Jul. 25, 2014”, 25 pgs. |
“U.S. Appl. No. 13/836,665, Non Final Office Action dated Jan. 30, 2014”, 21 pgs. |
“U.S. Appl. No. 13/836,665, Notice of Allowance dated Jun. 9, 2015”, 10 pgs. |
“U.S. Appl. No. 13/836,665, Response filed Jan. 23, 2015 to Final Office Action dated Jul. 25, 2014”, 25 pgs. |
“U.S. Appl. No. 13/836,665, Response filed May 30, 2014 to Non-Final Office Action dated Jan. 30, 2014”, 21 pgs. |
“U.S. Appl. No. 13/837,294, Final Office Action dated Apr. 25, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Final Office Action dated Jun. 2, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Non Final Office Action dated Dec. 10, 2015”, 8 pgs. |
“U.S. Appl. No. 13/837,294, Notice of Allowance dated Aug. 25, 2016”, 5 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Mar. 4, 2016 to Non Final Office Action dated Dec. 10, 2015”, 16 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Aug. 3, 2016 to Final Office Action dated Jun. 2, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Oct. 12, 2015 to Restriction Requirement dated Aug. 24, 2015”, 9 pgs. |
“U.S. Appl. No. 13/837,294, Restriction Requirement dated Aug. 24, 2015”, 6 pgs. |
“U.S. Appl. No. 13/837,774, Examiner Interview Summary dated Jul. 22, 2014”, 4 pgs. |
“U.S. Appl. No. 13/837,774, Final Office Action dated Mar. 17, 2016”, 14 pgs. |
“U.S. Appl. No. 13/837,774, Final Office Action dated Jul. 28, 2014”, 17 pgs. |
“U.S. Appl. No. 13/837,774, Non Final Office Action dated Feb. 10, 2014”, 33 pgs. |
“U.S. Appl. No. 13/837,774, Non Final Office Action dated Sep. 18, 2015”, 16 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jan. 28, 2015 to Final Office Action dated Jul. 28, 2014”, 16 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jun. 10, 2014 to Non-Final Office Action dated Feb. 20, 2014”, 29 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jul. 7, 2015 to Restriction Requirement dated May 20, 2015”, 10 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Dec. 16, 2015 to Non Final Office Action dated Sep. 18, 2015”, 17 pgs. |
“U.S. Appl. No. 13/837,774, Restriction Requirement dated May 20, 2015”, 6 pgs. |
“U.S. Appl. No. 14/034,076, Appeal Brief Filed Apr. 18, 2016”, 21 pgs. |
“U.S. Appl. No. 14/034,076, Final Office Action dated Dec. 21, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,076, Non Final Office Action dated Jun. 24, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,076, Notice of Allowance dated Oct. 28, 2016”, 7 pgs. |
“U.S. Appl. No. 14/034,076, Response filed Nov. 16, 2015 to Non Final Office Action dated Jun. 24, 2015”, 13 pgs. |
“U.S. Appl. No. 14/034,937, Appeal Brief Filed Sep. 9, 2015”, 41 pgs. |
“U.S. Appl. No. 14/034,937, Appeal Decision mailed May 30, 2017”, 34 pgs. |
“U.S. Appl. No. 14/034,937, Final Office Action dated Jun. 5, 2015”, 22 pgs. |
“U.S. Appl. No. 14/034,937, Non Final Office Action dated Jan. 2, 2015”, 21 pgs. |
“U.S. Appl. No. 14/034,937, Notice of Allowance dated Aug. 30, 2017”, 14 pgs. |
“U.S. Appl. No. 14/034,937, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,937, PTO Response to Rule 312 Communication dated Oct. 10, 2017”, 2 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Mar. 30, 2015 to Non-Final Office Action”, 24 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Oct. 27, 2014 to Restriction Requirement dated Sep. 11, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,937, Restriction Requirement dated Sep. 11, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,937, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,944, Non Final Office Action dated Mar. 3, 2015”, 16 pgs. |
“U.S. Appl. No. 14/034,944, Notice of Allowance dated Aug. 28, 2015”, 7 pgs. |
“U.S. Appl. No. 14/034,944, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,944, Response filed Jun. 23, 2015 to Non Final Office Action dated Mar. 3, 2015”, 15 pgs. |
“U.S. Appl. No. 14/034,944, Response filed Dec. 15, 2014 to Restriction Requirement dated Oct. 14, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,944, Restriction Requirement dated Oct. 14, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,944, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Advisory Action dated Aug. 25, 2015”, 3 pgs. |
“U.S. Appl. No. 14/034,954, Final Office Action dated Jun. 1, 2015”, 26 pgs. |
“U.S. Appl. No. 14/034,954, Non Final Office Action dated Dec. 19, 2014”, 25 pgs. |
“U.S. Appl. No. 14/034,954, Notice of Allowance dated Nov. 20, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Mar. 17, 2015 to Non Final Office Action dated Dec. 19, 2014”, 21 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Aug. 3, 2015 to Final Office Action dated Jun. 1, 2015”, 19 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Aug. 31, 2015 to Advisory Action dated Aug. 25, 2015”, 21 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Oct. 27, 2014 to Restriction Requirement dated Aug. 25, 2014”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Restriction Requirement dated Aug. 25, 2014”, 7 pgs. |
“U.S. Appl. No. 14/034,954, Supplemental Preliminary Amendment filed Oct. 25, 2013”, 8 pgs. |
“U.S. Appl. No. 14/034,963, Final Office Action dated Apr. 13, 2015”, 22 pgs. |
“U.S. Appl. No. 14/034,963, Final Office Action dated Oct. 13, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,963, Non Final Office Action dated Jul. 1, 2015”, 15 pgs. |
“U.S. Appl. No. 14/034,963, Non Final Office Action dated Nov. 21, 2014”, 19 pgs. |
“U.S. Appl. No. 14/034,963, Notice of Allowance dated Dec. 18, 2015”, 5 pgs. |
“U.S. Appl. No. 14/034,963, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Mar. 20, 2015 to Non-Final Office Action dated Nov. 21, 2014”, 20 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Jun. 19, 2015 to Final Office Action dated Apr. 13, 2015”, 17 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Sep. 30, 2015 to Non Final Office Action dated Jul. 1, 2015”, 14 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Nov. 20, 2015 to Final Office Action dated Oct. 13, 2015”, 12 pgs. |
“U.S. Appl. No. 14/063,032, Non Final Office Action dated Jun. 20, 2014”, 6 pgs. |
“U.S. Appl. No. 14/063,032, Notice of Allowance dated Dec. 19, 2014”, 6 pgs. |
“U.S. Appl. No. 14/063,032, Preliminary Amendment filed Oct. 25, 2013”, 3 pgs. |
“U.S. Appl. No. 14/063,032, Response filed Oct. 20, 2014 to Non-Final Office Action dated Jun. 20, 2014”, 9 pgs. |
“U.S. Appl. No. 14/063,593, Advisory Action dated Aug. 19, 2016”, 3 pgs. |
“U.S. Appl. No. 14/063,593, Final Office Action dated Jun. 9, 2016”, 10 pgs. |
“U.S. Appl. No. 14/063,593, Non Final Office Action dated Jan. 25, 2016”, 9 pgs. |
“U.S. Appl. No. 14/063,593, Non Final Office Action dated Nov. 30, 2016”, 12 pgs. |
“U.S. Appl. No. 14/063,593, Notice of Allowance dated May 2, 2017”, 5 pgs. |
“U.S. Appl. No. 14/063,593, Notice of Allowance dated May 25, 2017”, 5 pgs. |
“U.S. Appl. No. 14/063,593, Preliminary Amendment filed Oct. 25, 2013”, 3 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Jan. 4, 2016 to Restriction Requirement dated Nov. 6, 2015”, 6 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Feb. 24, 2017 to Non Final Office Action dated Nov. 30, 2016”, 17 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Apr. 20, 2016 to Non Final Office Action dated Jan. 25, 2016”, 17 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Aug. 11, 2016 to Final Office Action dated Jun. 9, 2016”, 10 pgs. |
“U.S. Appl. No. 14/063,593, Restriction Requirement dated Nov. 6, 2015”, 6 pgs. |
“U.S. Appl. No. 14/181,033, Non Final Office Action dated May 1, 2015”, 5 pgs. |
“U.S. Appl. No. 14/181,033, Notice of Allowance dated Jul. 17, 2015”, 10 pgs. |
“U.S. Appl. No. 14/181,033, Response filed Jun. 22, 2015 to Non-Final Office Action dated May 1, 2015”, 11 pgs. |
“U.S. Appl. No. 14/278,805, Notice of Allowance dated Dec. 1, 2015”, 8 pgs. |
“U.S. Appl. No. 14/278,805, Supplemental Notice of Allowability dated Jan. 21, 2016”, 2 pgs. |
“U.S. Appl. No. 14/284,028, Non Final Office Action dated Jul. 7, 2015”, 17 pgs. |
“U.S. Appl. No. 14/284,028, Notice of Allowance dated Nov. 6, 2015”, 5 pgs. |
“U.S. Appl. No. 14/284,028, Response filed Oct. 6, 2015 to Non Final Office Action dated Jul. 7, 2015”, 15 pgs. |
“U.S. Appl. No. 14/284,028, Supplemental Notice of Allowability dated Feb. 26, 2016”, 5 pgs. |
“U.S. Appl. No. 14/284,028, Supplemental Preliminary Amendment filed Jul. 8, 2014”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Final Office Action dated Aug. 7, 2015”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Non Final Office Action dated Mar. 25, 2015”, 26 pgs. |
“U.S. Appl. No. 14/284,144, Notice of Allowance dated Oct. 29, 2015”, 8 pgs. |
“U.S. Appl. No. 14/284,144, Preliminary Amendment filed May 21, 2014”, 3 pgs. |
“U.S. Appl. No. 14/284,144, Response filed Oct. 9, 2015 to Final Office Action dated Aug. 7, 2015”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Response filed Jun. 23, 2015 to Non Final Office Action dated Mar. 25, 2015”, 22 pgs. |
“U.S. Appl. No. 14/284,144, Supplemental Preliminary Amendment filed Jul. 3, 2014”, 10 pgs. |
“U.S. Appl. No. 14/304,009, Notice of Allowance dated Nov. 16, 2016”, 7 pgs. |
“U.S. Appl. No. 14/304,009, Preliminary Amendment Filed Jul. 31, 2014”, 7 pgs. |
“U.S. Appl. No. 14/471,440, Notice of Allowance dated Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/471,440, Response filed Aug. 16, 2017 to Restriction Requirement dated Jun. 30, 2017”, 8 pgs. |
“U.S. Appl. No. 14/471,440, Restriction Requirement dated Jun. 30, 2017”, 6 pgs. |
“U.S. Appl. No. 14/490,153, Final Office Action dated Apr. 15, 2015”, 18 pgs. |
“U.S. Appl. No. 14/490,153, Non Final Office Action dated Nov. 12, 2014”, 9 pgs. |
“U.S. Appl. No. 14/490,153, Notice of Allowance dated Aug. 14, 2015”, 10 pgs. |
“U.S. Appl. No. 14/490,153, Preliminary Amendment filed Sep. 18, 2014”, 3 pgs. |
“U.S. Appl. No. 14/490,153, Response filed Feb. 18, 2015 to Non-Final Office Action dated Nov. 12, 2014”, 14 pgs. |
“U.S. Appl. No. 14/490,153, Response filed Jul. 7, 2015 to Final Office Action dated Apr. 15, 2015”, 14 pgs. |
“U.S. Appl. No. 14/660,217, Corrected Notice of Allowance dated May 26, 2016”, 3 pgs. |
“U.S. Appl. No. 14/660,217, Non Final Office Action dated Dec. 17, 2015”, 8 pgs. |
“U.S. Appl. No. 14/660,217, Notice of Allowance dated Apr. 26, 2016”, 5 pgs. |
“U.S. Appl. No. 14/660,217, Preliminary Amendment filed Mar. 18, 2015”, 9 pgs. |
“U.S. Appl. No. 14/660,217, Response filed Mar. 23, 2016 to Non Final Office Action dated Dec. 17, 2015”, 14 pgs. |
“U.S. Appl. No. 14/740,690, Non Final Office Action dated Dec. 7, 2016”, 19 pgs. |
“U.S. Appl. No. 14/740,690, Notice of Allowability dated Aug. 29, 2017”, 2 pgs. |
“U.S. Appl. No. 14/740,690, Notice of Allowance dated Jun. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/740,690, Response filed Mar. 3, 2017 to Non Final Office Action dated Dec. 7, 2016”, 14 pgs. |
“U.S. Appl. No. 14/791,952, Corrected Notice of Allowance dated Jul. 21, 2017”, 2 pgs. |
“U.S. Appl. No. 14/791,952, Final Office Action dated Mar. 31, 2017”, 8 pgs. |
“U.S. Appl. No. 14/791,952, Final Office Action dated Sep. 1, 2016”, 17 pgs. |
“U.S. Appl. No. 14/791,952, Non Final Office Action dated Apr. 21, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Non Final Office Action dated Dec. 29, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Notice of Allowance dated May 30, 2017”, 7 pgs. |
“U.S. Appl. No. 14/791,952, Preliminary Amendment filed Jul. 7, 2015”, 7 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Mar. 20, 2017 to Non Final Office Action dated Dec. 29, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Response filed May 17, 2017-to Final Office Action dated Mar. 31, 2017”, 10 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Jul. 15, 2016 to Non Final Office Action dated Apr. 21, 2016”, 18 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Nov. 21, 2016 to Final Office Action dated Sep. 1, 2016”, 15 pgs. |
“U.S. Appl. No. 14/833,385, Examiner Interview Summary dated Dec. 27, 2017”, 3 pgs. |
“U.S. Appl. No. 14/833,385, Final Office Action dated Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/833,385, Non Final Office Action dated Jun. 19, 2017”, 10 pgs. |
“U.S. Appl. No. 14/833,385, Preliminary Amendment filed Aug. 25, 2015”, 6 pgs. |
“U.S. Appl. No. 14/833,385, Response filed May 12, 2017 to Restriction Requirement dated Mar. 17, 2017”, 8 pgs. |
“U.S. Appl. No. 14/833,385, Response filed Sep. 18, 2017 to Non Final Office Action dated Jun. 19, 2017”, 14 pgs. |
“U.S. Appl. No. 14/833,385, Restriction Requirement dated Mar. 17, 2017”, 6 pgs. |
“U.S. Appl. No. 14/918,721, Final Office Action dated Oct. 20, 2016”, 5 pgs. |
“U.S. Appl. No. 14/918,721, Non Final Office Action dated Jun. 16, 2016”, 6 pgs. |
“U.S. Appl. No. 14/918,721, Notice of Allowance dated Feb. 1, 2017”, 9 pgs. |
“U.S. Appl. No. 14/918,721, Preliminary Amendment filed Oct. 23, 2015”, 8 pgs. |
“U.S. Appl. No. 14/918,721, PTO Response to Rule 312 Communication dated Mar. 17, 2017”, 2 pgs. |
“U.S. Appl. No. 14/918,721, Response filed Sep. 12, 2016 to Non Final Office Action dated Jun. 16, 2016”, 12 pgs. |
“U.S. Appl. No. 14/918,721, Response filed Dec. 13, 2016 to Final Office Action dated Oct. 20, 2016”, 9 pgs. |
“U.S. Appl. No. 14/926,281, Non Final Office Action dated Jun. 21, 2017”, 17 pgs. |
“U.S. Appl. No. 14/926,281, Notice of Allowance dated Nov. 16, 2017”, 9 pgs. |
“U.S. Appl. No. 14/926,281, Preliminary Amendment filed Oct. 30, 2015”, 8 pgs. |
“U.S. Appl. No. 14/926,281, Response filed Sep. 18, 2017 to Non Final Office Action dated Jun. 21, 2017”, 11 pgs. |
“U.S. Appl. No. 15/003,091, Preliminary Amendment filed Jan. 22, 2016”, 12 pgs. |
“U.S. Appl. No. 15/003,091, Non Final Office Action dated Jun. 20, 2017”, 14 pgs. |
“U.S. Appl. No. 15/003,091, Notice of Allowance dated Nov. 6, 2017”, 8 pgs. |
“U.S. Appl. No. 15/003,091, PTO Response to Rule 312 Communication dated Jan. 23, 2018”, 2 pgs. |
“U.S. Appl. No. 15/003,091, Response filed Sep. 20, 2017 to Non Final Office Action dated Jun. 20, 2017”, 17 pgs. |
“U.S. Appl. No. 15/045,799, Non Final Office Action dated Nov. 1, 2016”, 8 pgs. |
“U.S. Appl. No. 15/045,799, Notice of Allowance dated Mar. 10, 2017”, 10 pgs. |
“U.S. Appl. No. 15/045,799, Preliminary Amendment filed Feb. 18, 2016”, 9 pgs. |
“U.S. Appl. No. 15/045,799, PTO Response to Rule 312 Communication dated Apr. 18, 2017”, 2 pgs. |
“U.S. Appl. No. 15/045,799, Response filed Feb. 1, 2017 to Non Final Office Action dated Nov. 1, 2016”, 15 pgs. |
“U.S. Appl. No. 15/062,252, Preliminary Amendment filed Mar. 9, 2016”, 8 pgs. |
“U.S. Appl. No. 15/062,262, Non Final Office Action dated Jul. 22, 2016”, 12 pgs. |
“U.S. Appl. No. 15/062,262, Notice of Allowance dated Jan. 31, 2017”, 5 pgs. |
“U.S. Appl. No. 15/062,262, PTO Response to Rule 312 Communication dated Mar. 7, 2017”, 2 pgs. |
“U.S. Appl. No. 15/062,262, Response filed Oct. 24, 2016 to Non Final Office Action dated Jul. 22, 2016”, 13 pgs. |
“U.S. Appl. No. 15/177,734, Non Final Office Action dated Feb. 10, 2017”, 21 pgs. |
“U.S. Appl. No. 15/177,734, Notice of Allowance dated May 17, 2017”, 7 pgs. |
“U.S. Appl. No. 15/177,734, Preliminary Amendment filed Jun. 22, 2016”, 8 pgs. |
“U.S. Appl. No. 15/177,734, Response filed Apr. 19, 2017 to Non Final Office Action dated Feb. 10, 2017”, 22 pgs. |
“U.S. Appl. No. 15/211,812, Non Final Office Action dated Jan. 27, 2017”, 5 pgs. |
“U.S. Appl. No. 15/211,812, Notice of Allowance dated May 31, 2017”, 5 pgs. |
“U.S. Appl. No. 15/211,812, Preliminary Amendment filed Sep. 8, 2016”, 8 pgs. |
“U.S. Appl. No. 15/211,812, Response filed Apr. 19, 2017 to Non Final Office Action dated Jan. 27, 2017”, 9 pgs. |
“U.S. Appl. No. 15/267,793, Non Final Office Action dated Jun. 14, 2018”, 12 pgs. |
“U.S. Appl. No. 15/267,793, Notice of Allowability dated Jan. 17, 2019”, 2 pgs. |
“U.S. Appl. No. 15/267,793, Notice of Allowance dated Dec. 21, 2018”, 5 pgs. |
“U.S. Appl. No. 15/267,793, Response Filed Apr. 11, 2018 to Restriction Requirement dated Feb. 16, 2018”, 8 pgs. |
“U.S. Appl. No. 15/267,793, Response filed Aug. 22, 2018 Non Final Office Action dated Jun. 14, 2018”, 16 pgs. |
“U.S. Appl. No. 15/267,793, Restriction Requirement dated Feb. 16, 2018”, 7 pgs. |
“U.S. Appl. No. 15/424,328, Non Final Office Action dated Jun. 23, 2017”, 5 pgs. |
“U.S. Appl. No. 15/424,328, Notice of Allowance dated Oct. 16, 2017”, 6 pgs. |
“U.S. Appl. No. 15/424,328, Preliminary Amendment filed Feb. 28, 2017”, 10 pgs. |
“U.S. Appl. No. 15/424,328, Response filed Sep. 20, 2017 to Non Final Office Action dated Jun. 23, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Final Office Action dated Dec. 15, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Non Final Office Action dated Jul. 26, 2017”, 10 pgs. |
“U.S. Appl. No. 15/435,620, Notice of Allowance dated Mar. 13, 2018”, 5 pgs. |
“U.S. Appl. No. 15/435,620, Preliminary Amendment filed Mar. 20, 2017”, 7 pgs. |
“U.S. Appl. No. 15/435,620, Response filed Feb. 12, 2018 to Final Office Action dated Dec. 15, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Response filed Oct. 25, 2017 to Non Final Office Action dated Jul. 26, 2017”, 13 pgs. |
“U.S. Appl. No. 15/616,561, Non Final Office Action dated Aug. 9, 2018”, 8 pgs. |
“U.S. Appl. No. 15/616,561, Notice of Allowability dated Feb. 12, 2019”, 2 pgs. |
“U.S. Appl. No. 15/616,561, Notice of Allowance dated Dec. 10, 2018”, 7 pgs. |
“U.S. Appl. No. 15/616,561, Preliminary Amendment filed Jun. 8, 2017”, 7 pgs. |
“U.S. Appl. No. 15/616,561, Response filed Nov. 8, 2018 to Non Final Office Action dated Aug. 9, 2018”, 11 pgs. |
“U.S. Appl. No. 15/703,678, Non Final Office Action dated Apr. 8, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,678, Notice of Allowance dated Sep. 17, 2019”, 7 pgs. |
“U.S. Appl. No. 15/703,678, Preliminary Amendment filed Sep. 28, 2017”, 9 pgs. |
“U.S. Appl. No. 15/703,678, Response Filed Jan. 3, 2019 to Restriction Requirement dated Nov. 5, 2018”, 8 pgs. |
“U.S. Appl. No. 15/703,678, Response filed Jul. 3, 2019 to Non-Final Office Action dated Apr. 8, 2019”, 20 pgs. |
“U.S. Appl. No. 15/703,678, Restriction Requirement dated Nov. 5, 2018”, 6 pgs. |
“U.S. Appl. No. 15/703,692, Corrected Notice of Allowability dated Jul. 8, 2019”, 2 pgs. |
“U.S. Appl. No. 15/703,692, Non Final Office Action dated Jan. 14, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,692, Notice of Allowance dated May 7, 2019”, 5 pgs. |
“U.S. Appl. No. 15/703,692, Preliminary Amendment filed Sep. 28, 2017”, 9 pgs. |
“U.S. Appl. No. 15/703,692, Response filed Apr. 4, 2019 to Non Final Office Action dated Jan. 14, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,698, Corrected Notice of Allowability dated Dec. 18, 2018”, 2 pgs. |
“U.S. Appl. No. 15/703,698, Non Final Office Action dated Apr. 6, 2018”, 7 pgs. |
“U.S. Appl. No. 15/703,698, Notice of Allowance dated Sep. 12, 2018”, 5 pgs. |
“U.S. Appl. No. 15/703,698, Preliminary Amendment filed Sep. 28, 2017”, 8 pgs. |
“U.S. Appl. No. 15/703,698, Response filed Jul. 6, 2018 to Non Final Office Action dated Apr. 6, 2018”, 10 pgs. |
“U.S. Appl. No. 15/703,713, Non Final Office Action dated Mar. 27, 2018”, 29 pgs. |
“U.S. Appl. No. 15/703,713, Notice of Allowance dated Sep. 25, 2018”, 11 pgs. |
“U.S. Appl. No. 15/703,713, Response Filed Jun. 15, 2018 to Non-Final Office Action dated Mar. 27, 2018”, 16 pgs. |
“U.S. Appl. No. 15/703,713, Preliminary Amendment filed Sep. 28, 2017”, 7 pgs. |
“U.S. Appl. No. 15/720,866, Final Office Action dated Feb. 28, 2020”, 10 pgs. |
“U.S. Appl. No. 15/720,866, Non Final Office Action dated Sep. 9, 2019”, 12 pgs. |
“U.S. Appl. No. 15/720,866, Response filed Jan. 9, 2020 to Non Final Office Action dated Sep. 9, 2019”, 11 pgs. |
“U.S. Appl. No. 15/720,866, Response filed Jul. 10, 2019 to Restriction Requirement dated May 14, 2019”, 10 pgs. |
“U.S. Appl. No. 15/720,866, Response filed Nov. 13, 2017 to Non Final Office Action dated Sep. 14, 2017”, 10 pgs. |
“U.S. Appl. No. 15/720,866, Restriction Requirement dated May 14, 2019”, 7 pgs. |
“U.S. Appl. No. 15/720,866, Preliminary Amendment filed Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 15/827,654, Examiner Interview Summary dated Apr. 26, 2019”, 4 pgs. |
“U.S. Appl. No. 15/827,654, Final Office Action dated Feb. 19, 2019”, 19 pgs. |
“U.S. Appl. No. 15/827,654, Non Final Office Action dated Sep. 7, 2018”, 21 pgs. |
“U.S. Appl. No. 15/827,654, Notice of Allowance dated Jul. 8, 2019”, 8 pgs. |
“U.S. Appl. No. 15/827,654, Preliminary Amendment filed Dec. 22, 2017”, 11 pgs. |
“U.S. Appl. No. 15/827,654, Response Filed May 20, 2019 to Final Office Action dated Feb. 19, 2019”, 17 pgs. |
“U.S. Appl. No. 15/827,654, Response filed Jun. 6, 2018 to Restriction Requirement dated Apr. 6, 2018”, 11 pgs. |
“U.S. Appl. No. 15/827,654, Response filed to Non Final Office Action dated Sep. 7, 2018”, 24 pgs. |
“U.S. Appl. No. 15/827,654, Restriction Requirement dated Apr. 6, 2018”, 6 pgs. |
“U.S. Appl. No. 15/890,735, Notice of Allowance dated Oct. 29, 2019”, 11 pgs. |
“U.S. Appl. No. 15/915,886, Non Final Office Action dated Aug. 2, 2019”, 9 pgs. |
“U.S. Appl. No. 15/915,886, Notice of Allowance dated Jan. 16, 2020”, 9 pgs. |
“U.S. Appl. No. 15/915,886, PTO Response to Rule 312 Communication dated May 8, 2020”, 2 pgs. |
“U.S. Appl. No. 15/915,886, Response Filed Nov. 4, 2019 to Non-Final Office Action dated Aug. 2, 2019”, 8 pgs. |
“U.S. Appl. No. 16/389,381, Non Final Office Action dated Mar. 30, 2020”, 9 pgs. |
“U.S. Appl. No. 16/530,423, Preliminary Amendment filed Aug. 28, 2019”, 7 pgs. |
“U.S. Appl. No. 16/596,194, Preliminary Amendment Filed Nov. 14, 2019”, 8 pgs. |
“U.S. Appl. No. 16/715,092, Preliminary Amendment filed Mar. 19, 2020”, 10 pgs. |
“U.S. Appl. No. 16/743,746, Preliminary Amendment filed Mar. 19, 2020”, 8 pgs. |
“Australian Application Serial No. 2011286306, First Examiner Report dated Jun. 19, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286306, Response filed Jun. 3, 2014 to First Examiner Report dated Jun. 19, 2013”, 16 pgs. |
“Australian Application Serial No. 2011286307, First Examiner Report dated Oct. 17, 2013”, 2 pgs. |
“Australian Application Serial No. 2011286307, Response filed May 21, 2014 to First Examiner Report dated Oct. 17, 2013”, 16 pgs. |
“Australian Application Serial No. 2011286308, First Examiner Report dated Jun. 21, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286308, Response filed Jun. 6, 2014 First Examiner Report dated Jun. 21, 2013”, 19 pgs. |
“Australian Application Serial No. 2011286309, First Examiner Report dated Jun. 21, 2013”, 3 pgs. |
“Australian Application Serial No. 2011286309, Response filed Jun. 10, 2014 to First Examiner Report dated Jun. 21, 2013”, 4 pgs. |
“Australian Application Serial No. 2011343440, First Examiner Report dated Feb. 17, 2014”, 3 pgs. |
“Australian Application Serial No. 2011343440, Response filed Mar. 21, 2014 to Office Action dated Feb. 17, 2014”, 1 pg. |
“Australian Application Serial No. 2012271243, Office Action dated Apr. 1, 2015”, 2 pgs. |
“Australian Application Serial No. 2012271243, Response filed Apr. 8, 2015 to Office Action dated Apr. 1, 2015”, 4 pgs. |
“Australian Application Serial No. 2012271243, Response filed Apr. 15, 2015 to Office Action dated Apr. 13, 2015”, 1 pg. |
“Australian Application Serial No. 2012271243, Subsequent Examiners Report dated Apr. 13, 2015”, 2 pgs. |
“Australian Application Serial No. 2012341026, First Examiner Report dated Jul. 14, 2014”, 2 pgs. |
“Australian Application Serial No. 2012341026, Response filed Nov. 21, 2014 to First Examiner Report dated Jul. 14, 2014”, 1 pg. |
“Australian Application Serial No. 2012341026, Statement of Proposed Amendment filed Jun. 18, 2014”, 25 pgs. |
“Australian Application Serial No. 2012368262, First Examiner Report dated Nov. 2, 2016”, 4 pgs. |
“Australian Application Serial No. 2012368262, Response filed Jan. 17, 2017 to Office Action dated Nov. 2, 2016”, 21 pgs. |
“Australian Application Serial No. 2012368262, Response filed May 15, 2017 to Subsequent Examiners Report dated Mar. 16, 2017”, 2 pgs. |
“Australian Application Serial No. 2012368262, Subsequent Examiners Report dated Mar. 16, 2017”, 3 pgs. |
“Australian Application Serial No. 2013238046, First Examiner Report dated Nov. 26, 2015”, 2 pgs. |
“Australian Application Serial No. 2013238046, Response filed Feb. 2, 2016 to First Examiner Report dated Nov. 26, 2015”, 1 pg. |
“Australian Application Serial No. 2013238054, First Examiner Report dated Oct. 17, 2016”, 4 pgs. |
“Australian Application Serial No. 2013238054, Response filed Jan. 18, 2017 to First Examiner Report dated Oct. 17, 2016”, 9 pgs. |
“Australian Application Serial No. 2014250709, First Examiner Report dated Dec. 21, 2015”, 3 pgs. |
“Australian Application Serial No. 2014250709, Response filed May 4, 2016 to First Examiner Report dated Dec. 21, 2015”, 12 pgs. |
“Australian Application Serial No. 2014250709, Subsequent Examiners Report dated May 31, 2016”, 6 pgs. |
“Australian Application Serial No. 2014250710, First Examiner Report dated Dec. 11, 2015”, 7 pgs. |
“Australian Application Serial No. 2014250710, Response filed Mar. 22, 2016 to First Examiner Report dated Dec. 11, 2015”, 18 pgs. |
“Australian Application Serial No. 2014250710, Response filed May 4, 2016 to Subsequent Examiners Report dated Mar. 23, 2016”, 15 pgs. |
“Australian Application Serial No. 2014250710, Subsequent Examiners Report dated Mar. 23, 2016”, 3 pgs. |
“Australian Application Serial No. 2014250711, First Examiner Report dated Feb. 12, 2016”, 7 pgs. |
“Australian Application Serial No. 2014250711, Response filed Apr. 27, 2016 to First Examiner Report dated Feb. 12, 2016”, 32 pgs. |
“Australian Application Serial No. 2015201511, First Examination Report dated Apr. 18, 2016”, 2 pgs. |
“Australian Application Serial No. 2015201511, Response filed Jun. 30, 2016 to First Examiner Report dated Apr. 18, 2016”, 12 pgs. |
“Australian Application Serial No. 2015238820, First Examination Report dated May 30, 2017”, 3 pgs. |
“Australian Application Serial No. 2015238820, Response filed Jul. 12, 2017 to First Examination Report dated May 30, 2017”, 12 pgs. |
“Australian Application Serial No. 2016225911, First Examiners Report dated Jun. 2, 2017”, 3 pgs. |
“Australian Application Serial No. 2016225911, Response filed Aug. 22, 2017 to First Examiners Report dated Jun. 2, 2017”, 18 pgs. |
“Australian Application Serial No. 2017235987, First Examination Report dated Nov. 1, 2018”, 4 pgs. |
“Australian Application Serial No. 2017251736, First Examiners Report dated Oct. 31, 2017”, 2 pgs. |
“Bi-Cruciate Stabilized Knee System”, Design Rationale, Smith & Nephew Journal, (2006), 20 pgs. |
“Brazil Application Serial No. BR1120130016698, Office Action dated Aug. 27, 2019”, (W/ English Translation), 8 pages. |
“Brazil Application Serial No. BR1120130016698, Response filed Dec. 9, 2019 to Office Action dated Aug. 27, 2019”, w/ English Claims, 22 pgs. |
“Brazil Application Serial No. BR1120130016736, Office Action dated Aug. 27, 2019”, (with English translation), 8 pages. |
“Brazil Application Serial No. BR1120130016736, Response filed Dec. 9, 2019 to Office Action dated Aug. 27, 2019”, w/ English Claims, 25 pgs. |
“Canadian Application Serial No. 2,806,321, Office Action dated Jan. 15, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,806,321, Response filed Jan. 22, 2018 to Office Action dated Jan. 15, 2018”, 7 pgs. |
“Canadian Application Serial No. 2,806,321, Response filed Dec. 6, 2017 to Office Action dated Jun. 15, 2017”, 12 pgs. |
“Canadian Application Serial No. 2,806,325, Office Action dated Mar. 14, 2016”, 4 pgs. |
“Canadian Application Serial No. 2,806,325, Response filed Sep. 14, 2016 to Office Action dated Mar. 14, 2016”, 17 pgs. |
“Canadian Application Serial No. 2,806,326, Examiner's Rule 30(2) Requisition dated Sep. 20, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Office Action dated Feb. 8, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Office Action dated Jun. 19, 2017”, 3 pgs. |
“Canadian Application Serial No. 2,806,326, Response Filed Mar. 20, 2019 to Examiner's Rule 30(2) Requisition dated Sep. 20, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Response filed Jul. 20, 2018 to Office Action dated Feb. 8, 2018”, 12 pgs. |
“Canadian Application Serial No. 2,821,927, Office Action dated Jan. 25, 2018”, 6 pgs. |
“Canadian Application Serial No. 2,821,927, Response filed Jul. 18, 2018 to Office Action dated Jan. 25, 2018”, 10 pgs. |
“Canadian Application Serial No. 2,821,927, Voluntary Amendment dated Jun. 14, 2013”, 7 pgs. |
“Canadian Application Serial No. 2,824,527, Office Action dated Mar. 17, 2014”, 2 pgs. |
“Canadian Application Serial No. 2,824,527, Response filed Sep. 17, 2014 to Office Action dated Mar. 17, 2014”, 14 pgs. |
“Canadian Application Serial No. 2,856,070, Preliminary Amendment filed May 25, 2015”, 27 pgs. |
“Canadian Application Serial No. 2,856,571 Response filed Jan. 22, 2015 to Office Action dated Jul. 22, 2014”, 24 pgs. |
“Canadian Application Serial No. 2,856,571, Office Action dated Jul. 22, 2014”, 2 pgs. |
“Canadian Application Serial No. 2,863,375, Office Action dated Apr. 20, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,863,375, Response filed Oct. 22, 2018 Office Action dated Apr. 20, 2018”, 12 pgs. |
“Canadian Application Serial No. 2,868,825, Office Action dated Dec. 27, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,956,119, Examiner's Rule 30(2) Requisition dated Sep. 27, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,956,119, Office Action dated Jan. 22, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,956,119, Response Filed Mar. 27, 2019 to Examiner's Rule 30(2) Requisition dated Sep. 27, 2018”, 7 pgs. |
“Canadian Application Serial No. 2,989,184, Office Action dated Oct. 1, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,989,184, Response filed Apr. 1, 2019 to Office Action dated Oct. 1, 2018”, 10 pgs. |
“Canadian Application Serial No. 2,806,321, Office Action dated Jun. 15, 2017”, 3 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Feb. 14, 2016”, (W/ English Translation), 17 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Mar. 29, 2015”, (W/ English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Aug. 12, 2015”, (W/ English Translation), 7 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Apr. 19, 2016 to Office Action dated Feb. 14, 2016”, No English Translation, 11 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Jun. 19, 2015 to Office Action dated Mar. 29, 2015”, (W/ English translation of claims), 11 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Oct. 27, 2015 to Office Action dated Aug. 12, 2015”, (W/ English translation of claims), 9 pgs. |
“Chinese Application Serial No. 201180045681.8, Office Action dated Jan. 22, 2015”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201180045681.8, Response filed May 14, 2015 to Office Action dated Jan. 22, 2015”, W/ English Claims, 17 pgs. |
“Chinese Application Serial No. 201180045683.7, Office Action dated Mar. 9, 2015”, (W/ English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045683.7, Response filed Jul. 14, 2015 to Office Action dated Mar. 9, 2015”, (W/ English translation of claims), 30 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Jan. 5, 2015”, (W/ English Translation), 4 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Feb. 2, 2016”, w/English Translation, 11 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Aug. 5, 2015”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201180045689.4, Response filed Apr. 7, 2016 to Office Action dated Feb. 2, 2016”, No English Translation, 8 pgs. |
“Chinese Application Serial No. 201180045689.4, Response filed May 1, 2015 to Office Action dated Jan. 5, 2015”, W/ English Claims, 13 pgs. |
“Chinese Application Serial No. 201180045689.4,Response filed Oct. 21, 2015 to Office Action dated Aug. 5, 2015”, No English Claims. |
“Chinese Application Serial No. 201180067430.X, Office Action dated Aug. 28, 2014”, (W/ English Translation), 8 pgs. |
“Chinese Application Serial No. 201180067430.X, Response filed Jan. 4, 2015 to Office Action dated Sep. 26, 2014”, (W/ English Translation), 14 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Mar. 2, 2015”, (W/ English Translation), 18 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Jun. 1, 2016”, (W/ English Translation), 10 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Nov. 16, 2015”, (W/ English Translation), 17 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Jan. 27, 2016 to Office Action dated Nov. 16, 2015”, (W/ English Translation of Claims), 12 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Jul. 10, 2015 to Office Action dated Mar. 2, 2015”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Aug. 11, 2016 to Office Action dated Jun. 1, 2016”, (W/ English Translation of Claims), 9 pgs. |
“Chinese Application Serial No. 201180067757.7, Voluntary Amendment dated Feb. 14, 2014”, (W/ English Translation of Claims), 8 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated Feb. 1, 2016”, (W/ English Translation), 4 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated May 20, 2015”, (W/ English Translation), 15 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated Nov. 20, 2015”, W/ English Translation of Claims, 7 pgs. |
“Chinese Application Serial No. 201280067473.2, Preliminary Amendment filed Jan. 29, 2015”, No English Translation or Claims Available, 10 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Apr. 7, 2016 to Office Action dated Feb. 1, 2016”, (W/ English translation of claims), 11 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Sep. 7, 2015 to Office Action dated May 20, 2015”, (W/ English translation of claims), 12 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Dec. 4, 2015 to Office Action dated Nov. 20, 2015”, w/English Claims, 11 pgs. |
“Chinese Application Serial No. 201280067481.7, Office Action dated Sep. 30, 2015”, (W/ English Translation), 7 pgs. |
“Chinese Application Serial No. 201280071940.9, Office Action dated Jul. 22, 2015”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201280071940.9, Preliminary Amendment filed Mar. 23, 2015”, W/ English Claims, 11 pgs. |
“Chinese Application Serial No. 201380028572.4, Office Action dated Aug. 13, 2015”, (W/ English Translation), 16 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Jun. 27, 2016”, (W/ English Translation), 8 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Nov. 4, 2015”, (W/ English Translation), 16 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Dec. 30, 2016”, (W/ English Translation), 4 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Feb. 8, 2017 to Office Action dated Dec. 30, 2016”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Mar. 18, 2016 to Office Action dated Nov. 4, 2015”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Sep. 6, 2016 to Office Action dated Jun. 27, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated May 24, 2017”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated Aug. 30, 2016”, (W/ English Translation), 14 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated Nov. 3, 2017”, (W/ English Translation), 10 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jan. 16, 2017 to Office Action dated Aug. 30, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jan. 18, 2018 to Office Action dated Nov. 3, 2017”, (W/ English Claims), 10 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jul. 10, 2017 to Office Action dated May 24, 2017”, (W/ English Translation), 10 pgs. |
“Chinese Application Serial No. 201510640436.1, Office Action dated Sep. 28, 2016”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201510640436.1, Response filed Feb. 16, 2017 to Office Action dated Sep. 28, 2016”, (W/ English Translation), 18 pgs. |
“Chinese Application Serial No. 201610634595.5, Office Action dated Apr. 20, 2018”, (W/ English Translation), 8 pgs. |
“Chinese Application Serial No. 201610634595.5, Office Action dated Jun. 21, 2017”, w/English Translation, 9 pgs. |
“Chinese Application Serial No. 201610634595.5, Response filed Jun. 4, 2018 to Office Action dated Apr. 20, 2018”, (W/ English Translation of Claims), 8 pgs. |
“Chinese Application Serial No. 201610634595.5, Response filed Nov. 3, 2017 to Office Action dated Jun. 21, 2017”, w/English Claims, 8 pgs. |
“Chinese Application Serial No. 201610685172.6, Office Action dated Apr. 10, 2017”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201610685172.6, Office Action dated Sep. 28, 2017”, (W/ English Translation), 9 pgs. |
“Chinese Application Serial No. 201610685172.6, Response filed Dec. 13, 2017 to Office Action dated Sep. 28, 2017”, (W/ English Claims), 13 pgs. |
“Chinese Application Serial No. 201680061268.3, Office Action dated Apr. 24, 2019”, (W/ English Translation), 11 pgs. |
“Chinese Application Serial No. 201680061268.3, Response filed Aug. 21, 2019 to Office Action dated Apr. 24, 2019”, (W/ English Claims), 8 pgs. |
“Complete Knee Solution Surgical Technique for the CR-Flex Fixed Bearing Knee”, Zimmer Nexgen, (2003), 22 pgs. |
“European Application Serial No. 11738918.9, Examination Notification Art. 94(3) dated Oct. 23, 2014”, 5 pgs. |
“European Application Serial No. 11738918.9, Preliminary Amendment dated Sep. 24, 2013”, 11 pgs. |
“European Application Serial No. 11738918.9, Response filed Mar. 2, 2015 to Examination Notification Art. 94(3) dated Oct. 23, 2014”, 14 pgs. |
“European Application Serial No. 11738919.7, Examination Notification Art. 94(3) dated Jul. 7, 2014”, 4 pgs. |
“European Application Serial No. 11738919.7, Preliminary Amendment filed Nov. 4, 2013”, 25 pgs. |
“European Application Serial No. 11738919.7, Response filed Nov. 13, 2014 to Examination Notification Art. 94(3) dated Jul. 7, 2014”, 14 pgs. |
“European Application Serial No. 11738920.5, Communication Pursuant to Article 94(3) EPC dated Mar. 15, 2016”, 4 pgs. |
“European Application Serial No. 11738920.5, Preliminary Amendment dated Sep. 24, 2013”, 9 pgs. |
“European Application Serial No. 11738920.5, Response filed Jul. 25, 2016 to Communication Pursuant to Article 94(3) EPC dated Mar. 15, 2016”, 6 pgs. |
“European Application Serial No. 11738920.5, Response filed Sep. 24, 2013 to Communication pursuant to Rules 161(2) and 162 EPC dated Mar. 15, 2013”, 22 pgs. |
“European Application Serial No. 11758060.5, Communication Pursuant to Article 94(3) EPC dated Jul. 12, 2016”, 3 pgs. |
“European Application Serial No. 11758060.5, Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2015”, 4 pgs. |
“European Application Serial No. 11758060.5, Preliminary Amendment filed Nov. 4, 2013”, 15 pgs. |
“European Application Serial No. 11758060.5, Response filed Apr. 21, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2015”, 16 pgs. |
“European Application Serial No. 11758060.5, Response filed Nov. 15, 2016 to Communication Pursuant to Article 94(3) EPC dated Jul. 12, 2016”, 23 pgs. |
“European Application Serial No. 11802835.6, Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2017”, 4 pgs. |
“European Application Serial No. 11802835.6, Response filed Apr. 23, 2018 to Office Action dated Dec. 11, 2017”, 16 pgs. |
“European Application Serial No. 11808493.8, Communication Pursuant to Article 94(3) EPC dated Dec. 7, 2015”, 4 pgs. |
“European Application Serial No. 11808493.8, Examination Notification Art. 94(3) dated Feb. 20, 2015”, 6 pgs. |
“European Application Serial No. 11808493.8, Response filed Feb. 26, 2014 to Communication pursuant to Rules 161(1) and 162 EPC dated Aug. 16, 2013”, 14 pgs. |
“European Application Serial No. 11808493.8, Response filed Apr. 18, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 7, 2015”, 15 pgs. |
“European Application Serial No. 11808493.8, Response filed Jul. 2, 2015 to Examination Notification Art. 94(3) dated Feb. 20, 2015”, 13 pgs. |
“European Application Serial No. 11815029.1, Communication Pursuant to Article 94(3) EPC dated Sep. 29, 2016”, 4 pgs. |
“European Application Serial No. 11815029.1, Extended European Search Report dated Dec. 10, 2013”, 8 pgs. |
“European Application Serial No. 11815029.1, Response filed Apr. 10, 2017 to Communication Pursuant to Article 94(3) EPC dated Sep. 29, 2016”, 22 pgs. |
“European Application Serial No. 11815029.1, Response filed Jul. 21, 2014 Extended European Search Report dated Dec. 10, 2013”, 15 pgs. |
“European Application Serial No. 12718882.9, Communication Pursuant to Article 94(3) EPC dated Dec. 1, 2015”, 11 pgs. |
“European Application Serial No. 12718882.9, Response filed Feb. 10, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 11 pgs. |
“European Application Serial No. 12718882.9, Response filed Apr. 11, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 1, 2015”, 12 pgs. |
“European Application Serial No. 12718883.7, Communication Pursuant to Article 94(3) EPC dated Dec. 2, 2015”, 4 pgs. |
“European Application Serial No. 12718883.7, Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 2 pgs. |
“European Application Serial No. 12718883.7, Intention to Grant dated May 20, 2016”, 5 pgs. |
“European Application Serial No. 12718883.7, Response filed Feb. 10, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 16 pgs. |
“European Application Serial No. 12718883.7, Response filed Apr. 12, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 2, 2015”, 30 pgs. |
“European Application Serial No. 12719236.7 Response filed Feb. 9, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 30, 2014”, 10 pgs. |
“European Application Serial No. 12719236.7, Decision to Grant dated Feb. 18, 2016”, 3 pgs. |
“European Application Serial No. 12719236.7, Office Action dated Aug. 27, 2015”, 7 pgs. |
“European Application Serial No. 12720352.9 Response filed Feb. 9, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 30, 2014”, 10 pgs. |
“European Application Serial No. 12756058.9, Communication Pursuant to Article 94(3) EPC dated Feb. 18, 2019”, 4 pgs. |
“European Application Serial No. 12756058.9, Office Action dated Jan. 17, 2017”, 5 Pgs. |
“European Application Serial No. 12756058.9, Preliminary Amendment filed Apr. 20, 2015”, 12 pgs. |
“European Application Serial No. 12756058.9, Response filed May 26, 2017 to Office Action dated Jan. 17, 2017”, 16 pgs. |
“European Application Serial No. 12756058.9, Response filed Jun. 28, 2019 to Communication Pursuant to Article 94(3) EPC dated Feb. 18, 2019”, 21 pgs. |
“European Application Serial No. 12756869.9 Response filed Feb. 10, 2015 to Communication Pursuant to Rule 161(1) and 162 EPC dated Jul. 31, 2014”, 14 pgs. |
“European Application Serial No. 12756869.9, Examination Notification Art. 94(3) dated Jul. 2, 2015”, 4 pgs. |
“European Application Serial No. 12756869.9, Response filed Nov. 12, 2015 to Examination Notification Art. 94(3) dated Jul. 2, 2015”, 28 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 94(3) EPC dated Nov. 16, 2015”, 4 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 94(3) EPC dated Nov. 17, 2016”, 4 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 94(3) EPC dated Jun. 6, 2016”, 5 pgs. |
“European Application Serial No. 13716636.9, Communication pursuant to Rules 161(1) and 162 EPC dated Dec. 12, 2014”, 2 pgs. |
“European Application Serial No. 13716636.9, Response filed Mar. 24, 2016 to Communication Pursuant to Article 94(3) EPC dated Nov. 16, 2015”, 18 pgs. |
“European Application Serial No. 13716636.9, Response filed Mar. 27, 2017 to Communication Pursuant to Article 94(3) EPC dated Nov. 17, 2016”, 15 pgs. |
“European Application Serial No. 13716636.9, Response filed Jun. 22, 2015 to Communication pursuant to Rules 161(1) and 162 EPC dated Dec. 12, 2014”, 10 pgs. |
“European Application Serial No. 13716636.9, Response filed Oct. 17, 2016 to Communication Pursuant to Article 94(3) EPC dated Jun. 6, 2016”, 5 pgs. |
“European Application Serial No. 14190180.1, Extended European Search Report dated Sep. 24, 2015”, 8 pgs. |
“European Application Serial No. 15160934.4, Communication Pursuant to Article 94(3) EPC dated Apr. 26, 2018”, 5 pgs. |
“European Application Serial No. 15160934.4, Extended European Search Report dated Jun. 1, 2016”, 8 pgs. |
“European Application Serial No. 15160934.4, Response filed Aug. 30, 2018 to Communication Pursuant to Article 94(3) EPC dated Apr. 26, 2018”, 63 pgs. |
“European Application Serial No. 15160934.4, Response filed Dec. 21, 2016 to Extended European Search Report dated Jun. 1, 2016”, 5 pgs. |
“European Application Serial No. 15174394.5, Extended European Search Report dated Mar. 21, 2016”, 8 pgs. |
“European Application Serial No. 15174394.5, Response filed Nov. 18, 2016 to Extended European Search Report dated Mar. 21, 2016”, 12 pgs. |
“European Application Serial No. 15191781.2, Communication Pursuant to Article 94(3) EPC dated Jan. 8, 2018”, 4 pgs. |
“European Application Serial No. 15191781.2, Extended European Search Report dated Mar. 1, 2017”, 8 pgs. |
“European Application Serial No. 15191781.2, Response filed May 17, 2018 to Communication Pursuant to Article 94(3) EPC dated Jan. 8, 2018”, 58 pgs. |
“European Application Serial No. 15191781.2, Response filed Sep. 28, 2017 to Extended European Search Report dated Mar. 1, 2017”, 14pgs. |
“European Application Serial No. 16156228.5, Extended European Search Report dated May 11, 2017”, 5 pgs. |
“European Application Serial No. 16183635.8, Extended European Search Report dated Jun. 30, 2017”, 9 pgs. |
“European Application Serial No. 16183635.8, Response filed Mar. 27, 2018 to Extended European Search Report dated Jun. 30, 2017”, 8 pgs. |
“European Application Serial No. 16189084.3, Extended European Search Report dated Oct. 9, 2017”, 9 pgs. |
“European Application Serial No. 16189084.3, Response filed May 10, 2018 to Extended European Search Report dated Oct. 9, 2017”, 20 pgs. |
“European Application Serial No. 16770657.1, Communication Pursuant to Article 94(3) EPC dated May 20, 2019”, 3 pgs. |
“European Application Serial No. 16770657.1, Response filed Sep. 30, 2019 to Communication Pursuant to Article 94(3) EPC dated May 20, 2019”, 26 pgs. |
“European Application Serial No. 16770657.1, Response filed Nov. 26, 2018 to Office Action dated May 14, 2018”, 17 pgs. |
“European Application Serial No. 17157909.7, Extended European Search Report dated Jul. 17, 2018”, 7 pgs. |
“European Application Serial No. 17157909.7, Response Filed Feb. 15, 2019 to Extended European Search Report dated Jul. 17, 2018”, 37 pgs. |
“European Application Serial No. 17163432.2, Extended European Search Report dated May 14, 2018”, 6 pgs. |
“European Application Serial No. 17163440.5, Extended European Search Report dated Jan. 3, 2019”, 16 pgs. |
“European Application Serial No. 17163440.5, Partial European Search Report dated Jul. 23, 2018”, 15 pgs. |
“European Application Serial No. 17163440.5, Response filed Jul. 22, 2019 to Extended European Search Report dated Jan. 3, 2019”, 14 pgs. |
“European Application Serial No. 17168095.2, Extended European Search Report dated Jun. 8, 2018”, 8 pgs. |
“European Application Serial No. 17168095.2, Response Filed Jan. 17, 2019 Extended European Search Report dated Jun. 8, 2018”, 29 pgs. |
“European Application Serial No. 17168308.9, Extended European Search Report dated Jun. 13, 2018”, 8 pgs. |
“European Application Serial No. 17168308.9, Response Filed Jan. 17, 2019 to Extended European Search Report dated Jun. 13, 2018”, 24 pgs. |
“European Application Serial No. 18206326.3, Extended European Search Report dated Apr. 15, 2019”, 10 pgs. |
“European Application Serial No. 18206326.3, Response filed Nov. 22, 2019 to Extended European Search Report dated Apr. 15, 2019”, 15 pgs. |
“European Application Serial No. 18711801.3, Response to Communication pursuant to Rules 161(1) and 162 EPC filed May 7, 2020”, 14 pgs. |
“European Application Serial No. 19171990.5, Extended European Search Report dated Oct. 16, 2019”, 8 pgs. |
“European Application Serial No. 19171990.5, Response filed May 13, 2020 to Extended European Search Report dated Oct. 16, 2019”, 31 pgs. |
“Gender Solutions Natural Knee Flex System: Because Men and Women are Different”, Zimmer, Inc., (2007, 2009), 6 pg. |
“Gender Solutions Natural Knee Flex System: Surgical Technique”, Zimmer, Inc., (2007, 2008, 2009), 36 pgs. |
“Gender Solutions Natural-Knee Flex System”, Zimmer, Inc., (2007, 2009), 6 pgs. |
“Indian Application Serial No. 1544/DELNP/2013, Office Action dated May 21, 2019”, (W/ English Translation), 10 pgs. |
“Indian Application Serial No. 1544/DELNP/2013, Response filed Nov. 18, 2019 to Office Action dated May 21, 2019”, (W/ English Translation), 34 pgs. |
“Indian Application Serial No. 1545/DELNP/2013, Office Action dated Dec. 9, 2019”, (with English translation), 8 pages. |
“International Application Serial No. PCT/US2011/045077, International Preliminary Report on Patentability dated Jul. 5, 2012”, 23 pgs. |
“International Application Serial No. PCT/US2011/045077, International Search Report and Written Opinion dated Jan. 9, 2012”, 15 pgs. |
“International Application Serial No. PCT/US2011/045078, International Preliminary Report on Patentability dated Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045078, International Search Report and Written Opinion dated Jan. 9, 2012”, 14 pgs. |
“International Application Serial No. PCT/US2011/045080, International Preliminary Report on Patentability dated Feb. 7, 2013”, 13 pgs. |
“International Application Serial No. PCT/US2011/045080, International Search Report dated Jan. 9, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2011/045080, Written Opinion dated Jan. 9, 2012”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Preliminary Report on Patentability dated Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Search Report dated Jan. 9, 2012”, 5 pgs. |
“International Application Serial No. PCT/US2011/045082, Written Opinion dated Jan. 9, 2012”, 10 pgs. |
“International Application Serial No. PCT/US2011/045083, International Preliminary Report on Patentability dated Feb. 7, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/045083, International Search Report dated Dec. 7, 2011”, 2 pgs. |
“International Application Serial No. PCT/US2011/045083, Written Opinion dated Dec. 7, 2011”, 6 pgs. |
“International Application Serial No. PCT/US2011/051021, International Preliminary Report on Patentability dated Mar. 21, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/051021, International Search Report dated Nov. 23, 2011”, 12 pgs. |
“International Application Serial No. PCT/US2011/051021, Written Opinion dated Nov. 23, 2011”, 7 pgs. |
“International Application Serial No. PCT/US2011/064435, International Preliminary Report on Patentability dated Jun. 27, 2013”, 9 pgs. |
“International Application Serial No. PCT/US2011/064435, Search Report dated Jun. 21, 2012”, 5 pgs. |
“International Application Serial No. PCT/US2011/064435, Written Opinion dated Jun. 21, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2011/065683, International Preliminary Report on Patentability dated Jun. 27, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/065683, International Search Report dated Apr. 24, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2011/065683, Written Opinion dated Apr. 24, 2012”, 10 pgs. |
“International Application Serial No. PCT/US2012/035679, International Preliminary Report on Patentability dated May 30, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2012/035679, International Search Report dated Jun. 8, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2012/035679, Written Opinion dated Jun. 8, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/035680, International Preliminary Report on Patentability dated May 30, 2014”, 13 pgs. |
“International Application Serial No. PCT/US2012/035680, Search Report dated Oct. 9, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/035680, Written Opinion dated Oct. 9, 2012”, 11 pgs. |
“International Application Serial No. PCT/US2012/035683, International Preliminary Report on Patentability dated May 30, 2014”, 9 pgs. |
“International Application Serial No. PCT/US2012/035683, International Search Report and Written Opinion dated Jun. 5, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2012/035684, International Preliminary Report on Patentability dated May 30, 2014”, 14 pgs. |
“International Application Serial No. PCT/US2012/035684, International Search Report dated Aug. 8, 2012”, 9 pgs. |
“International Application Serial No. PCT/US2012/035684, Written Opinion dated Jun. 8, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2012/052132, International Preliminary Report on Patentability dated Jun. 5, 2014”, 12 pgs. |
“International Application Serial No. PCT/US2012/052132, International Search Report dated Jan. 10, 2013”, 5 pgs. |
“International Application Serial No. PCT/US2012/052132, Invitation to Pay Additional Fees and Partial Search Report dated Nov. 15, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/052132, Written Opinion dated Jan. 10, 2013”, 10 pgs. |
“International Application Serial No. PCT/US2012/052340, International Preliminary Report on Patentability dated Aug. 14, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2012/052340, Search Report dated Oct. 12, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2012/052340, Written Opinion dated Oct. 12, 2012”, 6 pgs. |
“International Application Serial No. PCT/US2013/034286, International Preliminary Report on Patentability dated Oct. 9, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2013/034286, International Search Report dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034286, Written Opinion dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034293, International Preliminary Report on Patentability dated Oct. 9, 2014”, 9 pgs. |
“International Application Serial No. PCT/US2013/034293, International Search Report dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034293, Written Opinion dated Jun. 25, 2013”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, International Preliminary Report on Patentability dated Apr. 5, 2018”, 10 pgs. |
“International Application Serial No. PCT/US2016/052163, International Search Report dated Jan. 20, 2017”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, Invitation to Pay Add'l Fees and Partial Search Report dated Nov. 7, 2016”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, Written Opinion dated Jan. 20, 2017”, 8 pgs. |
“International Application Serial No. PCT/US2018/021571, International Preliminary Report on Patentability dated Sep. 19, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2018/021571, International Search Report dated Jun. 7, 2018”, 6 pgs. |
“International Application Serial No. PCT/US2018/021571, Written Opinion dated Jun. 7, 2018”, 6 pgs. |
“Intramedullary Instrumentation Surgical Technique for the NexGen Cruciate Retaining & Legacy Posterior Stabilized Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5973-102, Rev. 1, (1995,1997,1998), 36 pgs. |
“Japanese Application Serial No. 2015-162707, Office Action dated Jun. 28, 2016”, (W/ English Translation), 8 pgs. |
“Japanese Application Serial No. 2013-521854, Notice of Reason for Rejection dated Sep. 16, 2014”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2013-521854, Response filed Dec. 16, 2014 to Notice of Reason for Rejection dated Sep. 16, 2014”, W/ English Claims, 11 pgs. |
“Japanese Application Serial No. 2013-521855, Amendment filed Jul. 22, 2014”, (W/ English Translation), 20 pgs. |
“Japanese Application Serial No. 2013-521855, Office Action dated Mar. 24, 2015”, W/ English Translation, 8 pgs. |
“Japanese Application Serial No. 2013-521856, Notice of Allowance dated Jan. 5, 2016”, w/English Translation, 6 pgs. |
“Japanese Application Serial No. 2013-521856, Office Action dated Sep. 1, 2015”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2013-521856, Response filed Dec. 1, 2015 to Office Action dated Sep. 1, 2015”, w/English Translation, 9 pgs. |
“Japanese Application Serial No. 2013-521857, Notice of Allowance dated Feb. 9, 2016”, w/English Translation, 6 pgs. |
“Japanese Application Serial No. 2013-521857, Notice of Reasons for Rejection dated Aug. 18, 2015”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2013-521857, Preliminary Amendment filed May 18, 2014”, (W/ English translation of claims), 9 pgs. |
“Japanese Application Serial No. 2013-521857, Response filed Jan. 25, 2016 to Notice of Reasons for Rejection dated Aug. 18, 2015”, (W/ English Translation), 17 pgs. |
“Japanese Application Serial No. 2013-544655, Office Action dated Mar. 8, 2016”, (W/ English Translation), 8 pgs. |
“Japanese Application Serial No. 2013-544655, Office Action dated Sep. 29, 2015”, (W/ English Translation), 7 pgs. |
“Japanese Application Serial No. 2013-544655, Response filed Jan. 4, 2016 to Office Action dated Sep. 29, 2015”, (English Translation of Claims), 14 pgs. |
“Japanese Application Serial No. 2013-544655, Response filed Jul. 14, 2016 to Office Action dated Mar. 8, 2016”, (w/ English Translation of Claims), 13 pgs. |
“Japanese Application Serial No. 2013-544858, Request for Examination filed Feb. 4, 2014”, (With English Translation), 14 pgs. |
“Japanese Application Serial No. 2014-121515, Notice of Reasons for Rejection dated Jan. 5, 2016”, (W/ English Translation), 9 pgs. |
“Japanese Application Serial No. 2014-121515, Office Action dated Jun. 2, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-121515, Response filed May 11, 2016 to Notice of Reasons for Rejection dated Jan. 5, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Japanese Application Serial No. 2014-121515, Response filed Aug. 20, 2015 to Office Action dated Jun. 2, 2015”, (W/ English Translation of Claims), 6 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated May 31, 2016”, (W/ English Translation of Claims), 6 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated Jun. 30, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated Nov. 24, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Feb. 23, 2016 to Office Action dated Nov. 24, 2015”, (W/ English Translation of Claims), 15 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Jun. 8, 2016 to Office Action dated May 31, 2016”, (W/ English Translation of Claims), 14 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Sep. 28, 2015 to Office Action dated Jun. 30, 2015”, (W/ English Translation of Claims), 16 pgs. |
“Japanese Application Serial No. 2014-542301, Office Action dated May 12, 2015”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2014-542301, Response filed Aug. 10, 2015 to Office Action dated May 12, 2015”, (W/ English translation of claims), 21 pgs. |
“Japanese Application Serial No. 2014-554709, Office Action dated Jul. 5, 2016”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2014-554709, Preliminary Amendment filed Jul. 29, 2015”, (W/ English translation of claims), 8 pgs. |
“Japanese Application Serial No. 2014-554709, Response filed Dec. 19, 2016 to Office Action dated Jul. 5, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Japanese Application Serial No. 2015-162707, Office Action dated Nov. 29, 2016”, (W/ English Translation), 3 pgs. |
“Japanese Application Serial No. 2015-162707, Response filed Jan. 26, 2017 to Office Action dated Nov. 27, 2016”, (W/ English Translation), 16 pgs. |
“Japanese Application Serial No. 2015-199496, Office Action dated Sep. 6, 2016”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2015-199496, Response filed Dec. 5, 2016 to Office Action dated Sep. 6, 2016”, (W/ English Translation of Claims), 9 pgs. |
“Japanese Application Serial No. 2015-503563, Office Action dated Dec. 20, 2016”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2015-503563, Response Filed Mar. 13, 2017 to Office Action dated Dec. 20, 2016”, (W/ English Translation), 9 pgs. |
“Japanese Application Serial No. 2016-145390, Office Action dated Apr. 25, 2017”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2016-145390, Response filed Jul. 3, 2017 to Office Action dated Apr. 25, 2017”, (W/ English Translation of Claims), 16 pgs. |
“Japanese Application Serial No. 2017-161246, Office Action dated May 15, 2018”, (W/ English Translation), 6 pgs. |
“Journey II XR, Bi-Cruciate Retaining Knee System”, Smith & Nephew, Surgical Technique, (2015), 40 pgs. |
“Legacy Implant Options”, Nexgen Complete Knee Solution, (2002), 8 pgs. |
“LPS-Flex Fixed Bearing Knee: Surgical Technique”, Zimmer, Inc., (2004, 2007, 2008), 16 pgs. |
“Mexican Application Serial No. MX/a/201 3/000988, Office Action dated Mar. 18, 2015”, w/English Claims, 17 pgs. |
“Mexican Application Serial No. MX/a/2013/000988, Response filed Jun. 1, 2015 to Office Action dated Mar. 18, 2015”, (W/ English Translation), 12 pgs. |
“Mexican Application Serial No. MX/A/2013/000988. Office Action dated Jun. 5, 2015”, w/ summary in English, 6 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Final Office Action dated Feb. 4, 2016”, w/ summary in English, 4 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Office Action dated Feb. 19, 2015”, (W/ English Translation), 4 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Response filed Apr. 29, 2015 to Office Action dated Feb. 19, 2015”, W/ English Claims, 18 pgs. |
“MIS Minimally invasive Solution, The M/G Unicompartmental Knee Minimally Invasive Surgical Technique”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5791-02, (Aug. 14, 2008), 27 pgs. |
“Multi-Reference 4-in-1 Femoral Instrumentation Surgical Technique for NexGen Cruciate Retaining & NexGen Legacy Posterior Stabilized Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5973-402 Rev. 1, (1998, 2000), 18 pgs. |
“Natural-Knee II Primary System Surgical Technique”, Zimmer, Inc., (2005), 48 pgs. |
“Nexgen Complete Knee Solution”, Extramedullary/Intramedullary Tibial Resector: Surgical Technique, Zimmer, Inc. 97-5997-002-00 Rev. 2, (2000, 2008, 2009), 28 pgs. |
“Nexgen Complete Knee Solution”, Extramedullary/iniramedullary Tibial Resector: Surgical Technique, Zimmer, Inc. 97-5997-02 Rev 1, (2000), 26 pgs. |
“Nexgen Complete Knee Solution for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer Surgical Technique, 97-5964-102-00, (2004, 2007), 12 pgs. |
“NexGen Complete Knee Solution, Intramedullary Instrumentation Surgical Technique for the NexGen Cruciate Retaining & Legacy Posterior Stabilized Knee”, Zimmer, Inc., (1995, 1997, 1998), 1-33. |
“NexGen Implant Options Surgeon-Specific”, Zimmer Inc., (2000), 16 pgs. |
“NexGen LPS Fixed Knee: Surgical Technique”, Zimmer Inc., (2002, 2008), 44 pgs. |
“NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knees”, Zimmer, Inc., (2007, 2008), 4 pgs. |
“NexGen Trabecular Metal Modular Plates”, Zimmer Inc., (2007), 19 pgs. |
“Persona “Medial Congruent Articular Surface” System Overview”, Zimmer, Inc., (2015), 6 pgs. |
“Persona “The Personalized Knee System””, Medial Congruent Sales Training, Zimmer, Inc., (Jul. 2015), 53 pgs. |
“Persona “The Personalized Knee System” Medial Congruent Advanced Bearings”, Zimmer, Inc., (2015), 2 pgs. |
“Persona “The Personalized Knee System” Medial Congruent Articular Surface Design Rationale”, Zimmer, Inc., (2015), 20 pgs. |
“Persona “The Personalized Knee System” Persona Medial Congruent”, Mar. 24-28, 2015 at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting., (Mar. 2015), 1 pg. |
“Persona “The Personalized Knee System” Surgical Technique”, Zimmer, Inc., (2015), 72 pgs. |
“Persona Medial Congruent Articular Surface”, Sales Training, Zimmer Biomet, (Jan. 2016), 71 pgs. |
“PFC Sigma Knee System with Rotating Platform Technical/ Monograph”, Depuy RFC Sigma RP, 0611-29-050 (Rev. 3), (1999), 70 pgs. |
“Primary/Revision Surgical Technique for NexGen Rotating Hinge Knee (RHK)”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5880-02, (2002), 116 pgs. |
“Revision Instrumentation Surgical Technique for Legacy Knee Constrained Condylar Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5994-202, (2001), 61 pgs. |
“Russian Application Serial No. 2013106942, Office Action dated Apr. 16, 2015”, W/ English Translation, 5 pgs. |
“Russian Application Serial No. 2013106942, Response filed Jul. 15, 2015 Office Action dated Apr. 16, 2015”, (W/ English translation of claims), 146 pgs. |
“Russian Application Serial No. 2013106943, Office Action dated Jul. 1, 2015”, (W/ English Translation), 6 pgs. |
“Russian Application Serial No. 2013106943, Office Action dated Dec. 28, 2015”, w/ partial English Translation, 6 pgs. |
“Russian Application Serial No. 2013106943, Response filed Apr. 28, 2016 to Office Action dated Dec. 28, 2015”, (W/ English translation of claims), 19 pgs. |
“Russian Application Serial No. 2013106943, Response filed Oct. 30, 2015 to Office Action dated Jul. 1, 2015”, (W/ English translation of claims), 21 pgs. |
“South African Application Serial No. 2013/01327, Amendment filed Apr. 24, 2014”, W/ English Translation, 4 pgs. |
“South African Application Serial No. 2013/01328, Amendment filed Apr. 24, 2014”, W/ English Translation, 4 pgs. |
“Surgical Technique for Cruciate Retaining Knees and Revision Instrumentation Surgical Technique for Cruciate Retaining Augmentable Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5970-202, (2002), 130 pgs. |
“Surgical Technique for the CR-Flex Fixed Bearing Knee”, NexGen Complete Knee Solution, Zimmer, Inc., (2003), 22 pgs. |
“Surgical Technique for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5964-02, Rev. 1, (2000, 2002), 15 pgs. |
“Surgical Technique for the Legacy Posterior Stabilized Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5996-02, (2002), 43 pgs. |
“Surgical Technique—Nexgen Complete Knee Solution for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer, Inc., (2004, 2007), 12 pgs. |
“The Zimmer Institute Surgical Technique MIS Quad-Sparing Surgical Technique for Total Knee Arthroplasty”, NExGen Complete Knee Solution, (2004), 55 pgs. |
“Tibial Baseplate: Pocket Guide (United States Version)”, Zimmer, Inc.,, (2009), 17 pgs. |
“Trabecular Metal Monoblock Tibial Components”, Zimmer, Inc., (2007), 4 pgs. |
“Trabecular Metal Monoblock Tibial Components Surgical Technique Addendum”, Nexgen Zimmer, Inc., (2005, 2007), 12 pgs. |
“Trabecular Metal Tibial Tray: Surgical Technique”, NexGen Zimmer, Inc., (2007, 2009), 16 pgs. |
“Turkish Application Serial No. 11808493.8, Working Requirements mailed Feb. 17, 2020”, 3 pgs. |
“Turkish Application Serial No. 12718882.9, Working Requirements mailed Feb. 13, 2020”, 3 pgs. |
“Vanguard® ID Total Knee, Surgical Technique”, Zimmer Biomet; 0682.1-GLBL-en-REV0317, (2017), 36 pgs. |
“Zimmer MIS Intramedullary Instrumentation Surgical Technique for NexGen Cruciate Retaining & NexGen Legacy Posterior Stabilized Knees”, printed 2005, 2009, Zimmer, Inc., (2009), 45 pgs. |
“Zimmer Nexgen Cruciate Retaining (CR) and Legacy Knee Posterior Stabilized (LPS) Trabecular Metal Monoblock Tibias”, Zimmer, Inc Surgical Technique Addendum, 97-7253-34, Rev. 3, (2004), 11 pgs. |
“Zimmer NexGen CR-Flex and LPS-Flex Knees Surgical Technique with posterior Referencing Instrumentation.”, Zimmer Inc., (2010, 2011), 48 pgs. |
“Zimmer NexGen LCCK Surgical Technique for use with LCCK 4-in-1 Instrumentation”, Zimmer, Inc.; copyright 2009, 2010, 2011, (May 2011), 52 pgs. |
“Zimmer NexGen MIS Modular Tibial Plate and Keel Cemented Surgical Technique”, Zimmer Inc., (2006, 2011), 26 pgs. |
“Zimmer NexGen MIS Tibial Component”, Brochure-97-5950-001-00 7.5mm, (2005, 2006), 8 pgs. |
“Zimmer NexGen MIS Tibial Component Cemented Surgical Technique”, Zimmer, Inc, #97-5950-002-00 Rev.1 1.5ML, (2005), 14 pgs. |
“Zimmer NexGen MIS Tibial Component Cemented Surgical Technique”, Zimmer Inc., (2005, 2006, 2008, 2009, 2010), 16 pgs. |
“Zimmer NexGen Trabecular Metal Augments—Abbreviated Surgical Technique”, Zimmer, Inc., (2004, 2006), 6 pgs. |
“Zimmer NexGen Trabecular Metal Augments Surgical Technique for LCCK & Rotating Hing Knee Trabecular Metal Augments”, Zimmer, Inc. 97-5448-02, Rev. 1, (2004), 6 pgs. |
“Zimmer NexGen Trabecular Metal Primary Patella Surgical Technique”, Zimmer. Inc., 97-7255-112-00, (2005), 10 pgs. |
“Zimmer NexGen Trabecular Metal Tibial Tray”, Surgical Technique, Zimmer, Inc., (2007, 2009), 16 pgs. |
“Zimmer Patient Specific Instruments”, Surgical Techniques for NexGen Complete Knee Solution Zimmer, Inc., (2010), 16 pgs. |
Annayappa, Ramesh, “Tibial Prosthesis”, U.S. Appl. No. 13/189,328, filed Jul. 22, 2011, 82 pgs. |
Annayappa, Ramesh, et al., “Tibial Prosthesis”, U.S. Appl. No. 13/189,324, filed Jul. 22, 2011, 50 pgs. |
Bellemans, Johan, et al., “Is Neutral Mechanical Alignment Normal for All Patients?”, Clinical Orthopaedics and Related Research; DOI 10.1007/s11999-011-1936-5, (Jun. 9, 2011), 9 pgs. |
Ding, M., et al., “Age-related variations in the microstructure of human tibial cancellous bone”, Journal of Orthopaedic Research, 20(3), (2002), 615-621. |
Ding, M., et al., “Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis”, Journal of Bone & Joint Surgery (British), 85-B(6), (Aug. 2003), 906-912. |
Doyle, et al., “Comparative Analysis of Human Trabecular Bone and Polyurethane Foam”, Purdue University., 1 pg. |
Dunbar, M. J., et al., “Fixation of a Trabecular Metal Knee Arthroplasty Component: A Prospective Randomized Study”, The Journal of Bone & Joint Surgery (American), vol. 91-A(7), (Jul. 2009), 1578-1586. |
Edwards, Andrew, et al., “The Attachments of the Fiber Bundles of the Posterior Cruciate ligament: An Anatomic Study”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 23, No. 3, (Mar. 2008), 284-290. |
Freeman, M.A.R., et al., “The Movement of the Knee Studied by Magnetic Resonance Imaging”, Advanced Bearings—Clinical Orthopedics & Related Research 2003, (2003), 1 pg. |
Hofmann, Aaron A, et al., “Posterior Stabilization in Total Knee Arthroplasty with Use of an Ultracongruent Polyethylene”, The Journal of Arthroplasty vol. 15, No. 5, (2000), 576-583. |
Hutt, Jonathan, et al., “Functional joint line obliquity after kinematic total knee arthroplasty”, International Orthopaedics; DOI 10.1007/s00264-015-2733-7, (Mar. 21, 2015), 6 pgs. |
Hvid, Ivan, et al., “Trabecular bone Strength Patterns at the Proximal Tibial Epiphysis”, Journal of Orthopaedic Research, vol. 3, No. 4, (1985), 464-472. |
Klostermann, et al., “Distribution of bone mineral density with age and gender in the proximal tibia”, Clinical Biomechanics 19, 376-376. |
Lorenz, Stephan, et al., “Radiological evaluation of the anterolateral and posteromedial bundle insertion sites of the posterior cruciate ligament”, Knee Surg Sports Traumatol Arthosc, vol. 17, (2009), 683-690. |
Moorman, Claude, et al., “Tibial Insertion of the Posterior Cruciate Ligament: A Sagittal Plane Analysis Using Gross, Histologic, and Radiographic Methods”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 24, No. 3, (Mar. 2008), 269-275. |
Parisi, Raymond C, “Motion Facilitating Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/229,103, filed Sep. 9, 2011, 46 pgs. |
Partovi, Hamid, “Flow-Through Latch and Edge-Triggered Flip-Flop Hybrid Elements”, Proceedings of the IEEE International Solid-State Circuits Conference, Digest of Technical Papers and Slide Supplement, NexGen Inc., Milpitas, CA, (1996), 40 pgs. |
Siggelkow, Eik, et al., “Impact of Tibia Bearing Surface and Femoral Component Design on Flexion Kinematics During Lunge”, Mar. 28-31, 2015 at the Orthopaedic Research Society (ORS) Annual Meeting (Poster #1645), (Mar. 2015), 1 pg. |
Siggelkow, Eik, et al., “Impact of Tibia Bearing Surface Design on Deep Knee Bend Kinematics”, Mar. 24-28, 2015 at the AAOS Conference (Poster #P142), (Mar. 2015), 1 pg. |
Stilling, et al., “Superior fixation of pegged trabecular metal over screw-fixed pegged porous titanium fiber mesh”, Acta Orthopaedica., (2011), 177-186. |
Victor, Jan M. K., et al., “Constitutional Varus Does Not Affect Joint Line Orientation in the Coronal Plane”, Joint Line Orientation in the Coronal Plane; 472; DOI 10.1007/s11999-013-2898-6, (Jun. 4, 2013), pp. 98-104. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,338, filed Jul. 22, 2011, 58 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,339, filed Jul. 22, 2011, 52 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,336, filed Jul. 22, 2011, 60 pgs. |
U.S. Appl. No. 13/087,610 U.S. Pat. No. 8,603,101, filed Apr. 15, 2011, Provisional Tibial Prosthesis System. |
U.S. Appl. No. 14/063,032 U.S. Pat. No. 9,011,459, filed Oct. 25, 2013, Provisional Tibial Prosthesis System. |
U.S. Appl. No. 14/660,217 U.S. Pat. No. 9,427,337, filed Mar. 17, 2015, Provisional Tibial Prosthesis System. |
U.S. Appl. No. 15/211,812 U.S. Pat. No. 9,763,807, filed Jul. 15, 2016, Provisional Tibial Prosthesis System. |
U.S. Appl. No. 15/703,698 U.S. Pat. No. 10/188,530, filed Sep. 13, 2017, Provisional Tibial Prosthesis System. |
U.S. Appl. No. 13/189,324 U.S. Pat. No. 8,764,840, filed Jul. 22, 2011, Tibial Prosthesis. |
U.S. Appl. No. 14/284,144 U.S. Pat. No. 9,283,082, filed May 21, 2014, Methods Related to Seating of Bearing Component on Tibial Tray. |
U.S. Appl. No. 15/003,091 U.S. Pat. No. 9,918,844, filed Jan. 21, 2016, Tibial Prosthesis With a Fixed Bearing Component. |
U.S. Appl. No. 14/034,937 U.S. Pat. No. 9,861,490, filed Sep. 24, 2013, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/189,336 U.S. Pat. No. 8,613,775, filed Jul. 22, 2011, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 15/827,654 U.S. Pat. No. 10/470,889, filed Nov. 30, 2017, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 16/596,194, filed Oct. 8, 2019, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/189,328 U.S. Pat. No. 8,628,580, filed Jul. 22, 2011, Tibial Prosthesis. |
U.S. Appl. No. 14/063,593 U.S. Pat. No. 9,763,794, filed Oct. 25, 2013, Tibial Prosthesis. |
U.S. Appl. No. 15/703,678 U.S. Pat. No. 10,543,099, filed Sep. 13, 2017, Tibial Prosthesis. |
U.S. Appl. No. 16/715,092, filed Dec. 16, 2019, Tibial Prosthesis. |
U.S. Appl. No. 13/229,103 U.S. Pat. No. 8,591,594, filed Sep. 9, 2011, Motion Facilitating Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 14/034,963 U.S. Pat. No. 9,314,343, filed Sep. 24, 2013, Motion Facilitating Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 14/791,952 U.S. Pat. No. 9,763,795, filed Jul. 6, 2015, Motion Facilitating Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 15/703,692 U.S. Pat. No. 10,413,415, filed Sep. 13, 2017, Motion Facilitating Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 16/530,423, filed Aug. 2, 2019, Motion Facilitating Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/189,338 U.S. Pat. No. 8,568,486, filed Jul. 22, 2011, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 14/034,944 U.S. Pat. No. 9,192,480, filed Sep. 24, 2013, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/189,339 U.S. Pat. No. 8,574,304, filed Jul. 22, 2011, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 14/034,954 U.S. Pat. No. 9,295,557, filed Sep. 24, 2013, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/593,339 U.S. Pat. No. 8,758,444, filed Aug. 23, 2012, Tibial Baseplate With Asymmetric Placement of Fixation Structures. |
U.S. Appl. No. 14/278,805 U.S. Pat. No. 9,308,095, filed May 15, 2014, Tibial Baseplate With Asymmetric Placement of Fixation Structures. |
U.S. Appl. No. 15/045,799 U.S. Pat. No. 9,707,089, filed Feb. 17, 2016, Tibial Baseplate With Asymmetric Placement of Fixation Structures. |
U.S. Appl. No. 15/616,561 U.S. Pat. No. 10,265,181, filed Jun. 7, 2017, Tibial Baseplate With Asymmetric Placement of Fixation Structures. |
U.S. Appl. No. 13/459,037 U.S. Pat. No. 8,858,643, filed Apr. 27, 2012, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/490,153 U.S. Pat. No. 9,204,970, filed Sep. 18, 2014, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/926,281 U.S. Pat. No. 9,925,050, filed Oct. 29, 2015, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 13/594,543 U.S. Pat. No. 9,381,090, filed Aug. 24, 2012, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 15/177,734 U.S. Pat. No. 9,763,796, filed Jun. 9, 2016, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 15/703,713 U.S. Pat. No. 10,195,041, filed Sep. 13, 2017, Asymmetric Tibial Components for a Knee Prosthesis. |
U.S. Appl. No. 13/459,041 U.S. Pat. No. 9,072,607, filed Apr. 27, 2012, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/740,690 U.S. Pat. No. 9,788,954, filed Jun. 16, 2015, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 15/720,866, filed Sep. 29, 2017, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 13/459,048 U.S. Pat. No. 8,690,954, filed Apr. 27, 2012, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/181,033 U.S. Pat. No. 9,186,255, filed Feb. 14, 2014, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/918,721 U.S. Pat. No. 9,655,728, filed Oct. 21, 2015, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 13/459,056 U.S. Pat. No. 8,764,838, filed Apr. 27, 2012, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/284,028 U.S. Pat. No. 9,295,558, filed May 21, 2014, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 15/062,262 U.S. Pat. No. 9,655,729, filed Mar. 7, 2016, Tibial Bearing Component for a Knee Prosthesis With Improved Articular Characteristics. |
U.S. Appl. No. 14/471,440 U.S. Pat. No. 9,925,052, filed Aug. 28, 2014, Method for Optimizing Implant Designs. |
U.S. Appl. No. 15/890,735 U.S. Pat. No. 10,575,959, filed Feb. 7, 2018, Method for Optimizing Implant Designs. |
U.S. Appl. No. 16/743,746, filed Jan. 15, 2020, Method for Optimizing Implant Designs. |
U.S. Appl. No. 15/267,793 U.S. Pat. No. 10,278,827, filed Sep. 16, 2016, Prosthesis System Including Tibial Bearing Component. |
U.S. Appl. No. 16/352,287, filed Mar. 13, 2019, Prosthesis System Including Tibial Bearing Component. |
U.S. Appl. No. 15/915,886 U.S. Pat. No. 10,675,153, filed Mar. 8, 2018, Tibial Prosthesis With Tibial Bearing Component Securing Feature. |
U.S. Appl. No. 16/849,394, filed Apr. 15, 2020, Tibial Prosthesis With Tibial Bearing Component Securing Feature. |
U.S. Appl. No. 16/179,201, filed Nov. 2, 2018, Implants for Adding Joint Inclination to a Knee Arthroplasty. |
U.S. Appl. No. 16/389,381, filed Apr. 19, 2019, Posterior Stabilized Prosthesis System. |
“U.S. Appl. No. 15/720,866, Notice of Allowance dated Sep. 23, 2020”, 7 pgs. |
“U.S. Appl. No. 15/720,866, PTO Response to Rule 312 Communication dated Nov. 20, 2020”, 2 pgs. |
“U.S. Appl. No. 15/720,866, Response filed May 27, 2020 to Final Office Action dated Feb. 28, 2020”, 13 pgs. |
“U.S. Appl. No. 16/179,201, Advisory Action dated Jun. 25, 2021”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Examiner Interview Summary dated Feb. 8, 2021”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Final Office Action dated Apr. 20, 2021”, 11 pgs. |
“U.S. Appl. No. 16/179,201, Non Final Office Action dated Nov. 2, 2020”, 15 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Jan. 28, 2021 to Non Final Office Action dated Nov. 2, 2020”, 16 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Jun. 18, 2021 to Final Office Action dated Apr. 20, 2021”, 16 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Oct. 5, 2020 to Restriction Requirement dated Aug. 7, 2020”, 9 pgs. |
“U.S. Appl. No. 16/179,201, Restriction Requirement dated Aug. 7, 2020”, 10 pgs. |
“U.S. Appl. No. 16/179,201, Supplemental Amendment & Response Filed Feb. 19, 2021 to Non-Final Office Action Filed Nov. 2, 2020”, 17 pgs. |
“U.S. Appl. No. 16/352,287, Final Office Action dated May 25, 2021”, 8 pgs. |
“U.S. Appl. No. 16/352,287, Non Final Office Action dated Dec. 10, 2020”, 12 pgs. |
“U.S. Appl. No. 16/352,287, Notice of Allowance dated Jun. 30, 2021”, 7 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Feb. 22, 2021 to Non Final Office Action dated Dec. 10, 2020”, 14 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Jun. 18, 2021 to Final Office Action dated May 25, 2021”, 8 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Oct. 12, 2020 to Restriction Requirement dated Aug. 17, 2020”, 8 pgs. |
“U.S. Appl. No. 16/389,381, Restriction Requirement dated Aug. 17, 2020”, 6 pgs. |
“U.S. Appl. No. 16/389,381, Notice of Allowance dated Jul. 16, 2020”, 5 pgs. |
“U.S. Appl. No. 16/389,381, Response filed Jun. 19, 2020 to Non Final Office Action dated Mar. 30, 2020”, 9 pgs. |
“U.S. Appl. No. 16/530,423, Non Final Office Action dated May 17, 2021”, 10 pgs. |
“U.S. Appl. No. 16/596,194, Final Office Action dated May 20, 2021”, 21 pgs. |
“U.S. Appl. No. 16/596,194, Non Final Office Action dated Jan. 22, 2021”, 19 pgs. |
“U.S. Appl. No. 16/596,194, Response filed Apr. 12, 2021 to Non Final Office Action dated Jan. 22, 2021”, 15 pgs. |
“U.S. Appl. No. 16/715,092, Restriction Requirement dated Jun. 25, 2021”, 6 pgs. |
“U.S. Appl. No. 16/849,394, Preliminary Amendment filed Jun. 3, 2020”, 7 pgs. |
“U.S. Appl. No. 17/068,435, Preliminary Amendment filed Nov. 13, 2020”, 7 pgs. |
“U.S. Appl. No. 17/134,885, Preliminary Amendment filed Jan. 18, 2021”, 10 pgs. |
“Australian Application Serial No. 2020204019, First Examination Report dated Jun. 18, 2021”, 7 pgs. |
“Brazilian Application Serial No. BR1120130016736, Response filed Oct. 5, 2020 to Office Action dated Jun. 10, 2020”, (W/ English Translation of Claims), 91 pgs. |
“Canadian Application Serial No. 3,063,415, Office Action dated Jul. 13, 2020”, 3 pgs. |
“Canadian Application Serial No. 3,063,415, Response filed Nov. 12, 2020 to Office Action dated Jul. 13, 2020”, 15 pgs. |
“Chinese Application Serial No. 201880016775.4, Office Action dated Jan. 22, 2021”, with English translation, 15 pages. |
“Chinese Application Serial No. 201880031319.7, Office Action dated May 15, 2020”, (W/ English Translation), 12 pgs. |
“Chinese Application Serial No. 201880031319.7, Office Action dated Nov. 18, 2020”, (W/ English Translation), 9 pgs. |
“Chinese Application Serial No. 201880031319.7, Response filed Jan. 18, 2021 to Office Action dated Nov. 18, 2020”, (W/ English Claims), 16 pgs. |
“Chinese Application Serial No. 201880031319.7, Response filed Jul. 22, 2020 to Office Action dated May 15, 2020”, (W/ English Claims), 10 pgs. |
“European Application Serial No. 18726670.5, Response to Communication pursuant to Rules 161(1) and 162 EPC filed Jul. 20, 2020”, 9 pgs. |
“European Application Serial No. 16189084.3, Communication Pursuant to Article 94(3) EPC dated Jul. 1, 2021”, 6 pgs. |
“European Application Serial No. 20175535.2, Partial European Search Report dated May 18, 2021”, 18 pgs. |
“Indian Application Serial No. 1545/DELNP/2013, Response filed Jun. 9, 2020 to Office Action dated Dec. 9, 2019”, (W/ English Claims), 78 pgs. |
“Japanese Application Serial No. 2019-562605, Notification of Reasons for Refusal dated Jun. 16, 2020”, (W/ English Translation), 7 pgs. |
“Japanese Application Serial No. 2019-562605, Notification of Reasons for Refusal dated Nov. 10, 2020”, with English translation, 5 pages. |
“Japanese Application Serial No. 2019-562605, Response filed Feb. 9, 2021 to Notification of Reasons for Refusal dated Nov. 10, 2020”, (W/ English Claims), 19 pgs. |
“Japanese Application Serial No. 2019-562605, Response filed Sep. 15, 2020 to Notification of Reasons for Refusal dated Jun. 16, 2020”, (W/ English Claims), 15 pgs. |
“Australian Application Serial No. 2018266322, First Examination Report dated Dec. 19, 2019”, 2 pgs. |
“International Application Serial No. PCT/US2018/031177, International Preliminary Report on Patentability dated Nov. 21, 2019”, 8 pgs. |
“U.S. Appl. No. 16/179,201, Examiner Interview Summary dated Nov. 9, 2021”, 4 pgs. |
“U.S. Appl. No. 16/179,201, Examiner Interview Summary dated Nov. 17, 2021”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Non Final Office Action dated Sep. 22, 2021”, 11 pgs. |
“U.S. Appl. No. 16/530,423, Final Office Action dated Nov. 4, 2021”, 11 pgs. |
“U.S. Appl. No. 16/530,423, Response filed Aug. 11, 2021 to Non Final Office Action dated May 17, 2021”, 15 pgs. |
“U.S. Appl. No. 16/596,194, Notice of Allowance dated Sep. 9, 2021”, 10 pgs. |
“U.S. Appl. No. 16/596,194, Response filed Aug. 18, 2021 to Final Office Action dated May 20, 2021”, 15 pgs. |
“U.S. Appl. No. 16/715,092, Non Final Office Action dated Sep. 22, 2021”, 8 pgs. |
“U.S. Appl. No. 16/715,092, Response filed Aug. 9, 2021 to Restriction Requirement dated Jun. 25, 2021”, 7 pgs. |
“Australian Application Serial No. 2020204019, Response filed Aug. 19, 2021 to First Examination Report dated Jun. 18, 2021”, 3 pgs. |
“Australian Application Serial No. 2020204919, Response filed Oct. 15, 2021 to Subsequent Examiners Report dated Sep. 2, 2021”, 22 pgs. |
“Australian Application Serial No. 2020204019, Subsequent Examiners Report dated Sep. 2, 2021”, 4 pgs. |
“Chinese Application Serial No. 201880016775.4, Decision of Rejection dated Jul. 12, 2021”, (W/ English Translation), 13 pgs. |
“European Application Serial No. 16189084.3, Response filed Nov. 8, 2021 to Communication Pursuant to Article 94(3) EPC dated Jul. 1, 2021”, 61 pgs. |
“European Application Serial No. 20175535.2, Extended European Search Report dated Aug. 18, 2021”, 16 pgs. |
“Mexican Application Serial No. 2016/001734, Response filed Aug. 31, 2021 to Office Action dated Jun. 7, 2021”, (W/ English Translation of Claims), 29 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Dec. 3, 2021 to Non Final Office Action dated Sep. 22, 2021”, 11 pages. |
“U.S. Appl. No. 16/596,194, Amendment Under 1.312 Filed Dec. 7, 2021”, 9 pages. |
“Australian Application Serial No. 2020204019, Subsequent Examiners Report dated Nov. 16, 2021”, 3 pages. |
“U.S. Appl. No. 16/715,092, Response filed Dec. 10, 2021 to Non Final Office Action dated Sep. 22, 2021”, 14 pages. |
“U.S. Appl. No. 16/596,194, PTO Response to Rule 312 Communication dated Dec. 13, 2021”, 2 pages. |
Number | Date | Country | |
---|---|---|---|
20200069433 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
62505322 | May 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15971743 | May 2018 | US |
Child | 16675938 | US |